# EDGAR Filing Document

**Accession Number:** 0001643953
**File Stem:** 0001213900-26-048619
**Filing Date:** 2026-4
**Character Count:** 165682
**Document Hash:** d0856765eb5d16d74c0b91e3c9e21871
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-048619.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001213900-26-048619

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 99

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260428

**DATE AS OF CHANGE**: 20260428

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Purple Innovation, Inc.
- **CENTRAL INDEX KEY:** 0001643953
- **STANDARD INDUSTRIAL CLASSIFICATION:** HOUSEHOLD FURNITURE [2510]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 474078206
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37523
- **FILM NUMBER:** 26908837

**BUSINESS ADDRESS:**
- **STREET 1:** 4100 N. CHAPEL RIDGE RD
- **STREET 2:** SUITE 200
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043
- **BUSINESS PHONE:** 801-756-2600

**MAIL ADDRESS:**
- **STREET 1:** 4100 N. CHAPEL RIDGE RD
- **STREET 2:** SUITE 200
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Global Partner Acquisition Corp.
- **DATE OF NAME CHANGE:** 20150602

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**FORM 10-Q**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2026**

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**FOR THE TRANSITION PERIOD FROM _____________ TO _____________**

Commission File Number: **001-37523**

![](ea028623101_img1.jpg)

**PURPLE INNOVATION, INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **47-4078206** |
| (State or other jurisdiction of <br> incorporation or organization) | (I.R.S. Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **4100 NORTH CHAPEL RIDGE ROAD SUITE 200**<br> **LEHI, UTAH** | **84043** |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

Registrant's telephone number, including area code: **(801) 756-2600**

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Class A Common Stock, par value $0.0001 per share | PRPL | The NASDAQ Stock Market LLC |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Date File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ☒

As of April 27, 2026, 108,825,636 shares of the registrant's Class A common stock, $0.0001 par value per share, and 163,052 shares of the registrant's Class B common stock, $0.0001 par value per share, were outstanding.

**PURPLE INNOVATION, INC.**

**QUARTERLY REPORT ON FORM 10-Q**

**TABLE OF CONTENTS**

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | **Page** |
| **Part I.** | **[Financial Information](#a_001)** | **[Financial Information](#a_001)** | 1 |
|  | Item 1. | [Financial Statements (Unaudited):](#a_002) | 1 |
|  |  | [Condensed Consolidated Balance Sheets](#a_003) | 1 |
|  |  | [Condensed Consolidated Statements of Operations](#a_004) | 2 |
|  |  | [Condensed Consolidated Statements of Stockholders' Equity](#a_005) | 3 |
|  |  | [Condensed Consolidated Statements of Cash Flows](#a_006) | 4 |
|  |  | [Notes to Condensed Consolidated Financial Statements](#a_007) | 5 |
|  | Item 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#a_008) | 27 |
|  | Item 3. | [Quantitative and Qualitative Disclosures About Market Risk](#a_009) | 35 |
|  | Item 4. | [Controls and Procedures](#a_010) | 35 |
| **Part II.** | **[Other Information](#a_011)** | **[Other Information](#a_011)** | 36 |
|  | Item 1. | [Legal Proceedings](#a_012) | 36 |
|  | Item 1A. | [Risk Factors](#a_013) | 36 |
|  | Item 5. | [Other Information](#a_014) | 36 |
|  | Item 6. | [Exhibits](#a_015) | 37 |
|  | [Signatures](#a_016) | [Signatures](#a_016) | 38 |

---

i

**PART I. FINANCIAL INFORMATION**

**ITEM 1. <u>FINANCIAL STATEMENTS</u>**

**PURPLE INNOVATION, INC.**

**Condensed Consolidated Balance Sheets**

**(unaudited – in thousands, except for par value)**

---

| | | |
|:---|:---|:---|
|  | **March 31,<br> 2026** | **December 31,<br> 2025** |
| **Assets** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $24955 | $24345 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 21143 | 41272 |
| &nbsp;&nbsp;&nbsp;Inventories | 58088 | 59725 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses | 5829 | 5487 |
| &nbsp;&nbsp;&nbsp;Other current assets | 5562 | 5891 |
| Total current assets | 115577 | 136720 |
| Property and equipment, net | 75833 | 77961 |
| Operating lease right-of-use assets | 67085 | 67271 |
| Intangible assets, net | 6152 | 6346 |
| Other long-term assets | 7340 | 7961 |
| Total assets | $271987 | $296259 |
| **Liabilities and Stockholders' Equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $41992 | $40312 |
| &nbsp;&nbsp;&nbsp;Accrued compensation | 5913 | 7673 |
| &nbsp;&nbsp;&nbsp;Customer prepayments | 4738 | 5276 |
| &nbsp;&nbsp;&nbsp;Accrued rebates and allowances | 8573 | 13416 |
| &nbsp;&nbsp;&nbsp;Accrued warranty liabilities – current portion | 7498 | 7141 |
| &nbsp;&nbsp;&nbsp;Operating lease obligations – current portion | 16902 | 17366 |
| &nbsp;&nbsp;&nbsp;Other current liabilities | 7597 | 10339 |
| Total current liabilities | 93213 | 101523 |
| Related party debt | 119199 | 111305 |
| Accrued warranty liabilities, net of current portion | 19981 | 19570 |
| Operating lease obligations, net of current portion | 74997 | 75616 |
| Warrant liabilities | 23108 | 16150 |
| Other long-term liabilities | 1629 | 1764 |
| Total liabilities | 332127 | 325928 |
| Commitments and contingencies (Note 13) |  |  |
| Stockholders' equity (deficit): |  |  |
| &nbsp;&nbsp;&nbsp;Class A common stock; $0.0001 par value, 210,000 shares authorized; 108,634 issued and outstanding at March 31, 2026 and 108,246 issued and outstanding at December 31, 2025 | 11 | 11 |
| &nbsp;&nbsp;&nbsp;Class B common stock; $0.0001 par value, 90,000 shares authorized; 163 issued and outstanding at March 31, 2026 and at December 31, 2025 |  |  |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 595687 | 595582 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (655821) | (625280) |
| Total stockholders' equity (deficit) attributable to Purple Innovation, Inc. | (60123) | (29687) |
| &nbsp;&nbsp;&nbsp;Noncontrolling interest | (17) | 18 |
| Total stockholders' equity (deficit) | (60140) | (29669) |
| Total liabilities and stockholders' equity (deficit) | $271987 | $296259 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

**PURPLE INNOVATION, INC.**

**Condensed Consolidated Statements of Operations**

**(unaudited – in thousands, except per share amounts)**

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br> March 31,** | **Three Months Ended<br> March 31,** |
|  | **2026** | **2025** |
| Revenues, net | $95730 | $104171 |
| Cost of revenues: |  |  |
| &nbsp;&nbsp;&nbsp;Cost of revenues | 60535 | 62207 |
| &nbsp;&nbsp;&nbsp;Cost of revenues - restructuring related charges |  | 918 |
| Total cost of revenues | 60535 | 63125 |
| Gross profit | 35195 | 41046 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;Marketing and sales | 31557 | 36626 |
| &nbsp;&nbsp;&nbsp;General and administrative | 18033 | 14487 |
| &nbsp;&nbsp;&nbsp;Research and development | 2448 | 2452 |
| &nbsp;&nbsp;&nbsp;Restructuring, impairment and other related charges |  | 1960 |
| Total operating expenses | 52038 | 55525 |
| Operating loss | (16843) | (14479) |
| Other income (expense): |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense | (8219) | (4764) |
| &nbsp;&nbsp;&nbsp;Other income, net | 1491 | 69 |
| &nbsp;&nbsp;&nbsp;Change in fair value – warrant liabilities | (6958) | 49 |
| Total other expense, net | (13686) | (4646) |
| Net loss before income taxes | (30529) | (19125) |
| &nbsp;&nbsp;&nbsp;Income tax expense | (47) | (41) |
| Net loss | (30576) | (19166) |
| &nbsp;&nbsp;&nbsp;Net loss attributable to noncontrolling interest | (35) | (29) |
| Net loss attributable to Purple Innovation, Inc. | $(30541) | $(19137) |
| Net loss per share: |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $(0.28) | $(0.18) |
| &nbsp;&nbsp;&nbsp;Diluted | $(0.28) | $(0.18) |
| Weighted average common shares outstanding: |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 108386 | 107596 |
| &nbsp;&nbsp;&nbsp;Diluted | 108386 | 107596 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

**PURPLE INNOVATION, INC.**

**Condensed Consolidated Statements of Stockholders' Equity (Deficit)**

**(unaudited – in thousands)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Class A** | **Class A** | **Class B** | **Class B** | | | | | |
|  | **Common Stock** | **Common Stock** | **Common Stock** | **Common Stock** | | | | | |
|  | **Shares** | **Par Value** | **Shares** | **Par Value** | **Additional**<br>**Paid-in**<br>**Capital** |<br>**Accumulated**<br>**Deficit** | **Total<br> Stockholders'<br> Equity (Deficit) attributable to Purple**<br>**Innovation,**<br>**Inc.** |<br>**Noncontrolling**<br>**Interest** | **Total**<br>**Equity**<br>**(Deficit)** |
| **Balance – December 31, 2025** | 108246 | $11 | 163 | $— | $595582 | $(625280) | $(29687) | $18 | $(29669) |
| Net loss |  |  |  |  |  | (30541) | (30541) | (35) | (30576) |
| Stock-based compensation |  |  |  |  | 156 |  | 156 |  | 156 |
| Issuance of stock under equity compensation plans | 388 |  |  |  | (51) |  | (51) |  | (51) |
| **Balance – March 31, 2026** | 108634 | $11 | 163 | $— | $595687 | $(655821) | $(60123) | $(17) | $(60140) |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Class A** | **Class A** | **Class B** | **Class B** | | | | | |
|  | **Common Stock** | **Common Stock** | **Common Stock** | **Common Stock** | | | | | |
|  | **Shares** | **Par Value** | **Shares** | **Par Value** | **Additional**<br>**Paid-in**<br>**Capital** |<br>**Accumulated**<br>**Deficit** | **Total**<br>**Stockholders'**<br>**Equity** |<br>**Noncontrolling**<br>**Interest** |<br>**Total**<br>**Equity** |
| **Balance – December 31, 2024** | 107545 | $11 | 165 | $— | $594053 | $(573866) | $20198 | $11 | $20209 |
| Net loss |  |  |  |  |  | (19137) | (19137) | (29) | (19166) |
| Stock-based compensation |  |  |  |  | 368 |  | 368 |  | 368 |
| Issuance of stock under equity compensation plans | 410 |  |  |  | (81) |  | (81) |  | (81) |
| Impact of transactions affecting NCI |  |  |  |  | (8) |  | (8) | 8 |  |
| **Balance – March 31, 2025** | 107955 | $11 | 165 | $— | $594332 | $(593003) | $1340 | $(10) | $1330 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

**PURPLE INNOVATION, INC.**

**Condensed Consolidated Statements of Cash Flows**

**(unaudited – in thousands)**

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br> March 31,** | **Three Months Ended<br> March 31,** |
|  | **2026** | **2025** |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $(30576) | $(19166) |
| Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 4427 | 5050 |
| &nbsp;&nbsp;&nbsp;Non-cash interest | 3736 | 2120 |
| &nbsp;&nbsp;&nbsp;Paid-in-kind interest | 4504 | 2789 |
| &nbsp;&nbsp;&nbsp;Non-cash restructuring, impairment and other related charges |  | 635 |
| &nbsp;&nbsp;&nbsp;Loss on disposal of property and equipment | 66 | 88 |
| &nbsp;&nbsp;&nbsp;Change in fair value – warrant liabilities | 6958 | (49) |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 156 | 368 |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable | 20129 | 8669 |
| &nbsp;&nbsp;&nbsp;Inventories | 1637 | (3314) |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | 789 | 2229 |
| &nbsp;&nbsp;&nbsp;Operating leases, net | (897) | (848) |
| &nbsp;&nbsp;&nbsp;Accounts payable | 1377 | (9701) |
| &nbsp;&nbsp;&nbsp;Accrued compensation | (1760) | (1970) |
| &nbsp;&nbsp;&nbsp;Customer prepayments | (538) | (2685) |
| &nbsp;&nbsp;&nbsp;Accrued rebates and allowances | (4843) | (3854) |
| &nbsp;&nbsp;&nbsp;Accrued warranty liabilities | 768 | (487) |
| &nbsp;&nbsp;&nbsp;Other accrued liabilities | (2944) | (2944) |
| Net cash provided by (used in) operating activities | 2989 | (23070) |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;Sale of property and equipment |  | 258 |
| &nbsp;&nbsp;&nbsp;Purchase of property and equipment | (1612) | (2241) |
| &nbsp;&nbsp;&nbsp;Investment in intangible assets | (421) | (161) |
| Net cash used in investing activities | (2033) | (2144) |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from related party loan |  | 19000 |
| &nbsp;&nbsp;&nbsp;Payments for debt issuance costs | (346) | (1170) |
| Net cash provided by (used in) financing activities | (346) | 17830 |
| Net increase (decrease) in cash and cash equivalents | 610 | (7384) |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents, beginning of the period | 24345 | 29011 |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents, end of the period | $24955 | $21627 |
| Supplemental disclosures of cash flow information: |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid during the period for interest, net of amounts capitalized | $20 | $39 |
| &nbsp;&nbsp;&nbsp;Cash paid during the period for income taxes | $19 | $28 |
| Supplemental schedule of non-cash investing and financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;Property and equipment included in accounts payable | $519 | $459 |
| &nbsp;&nbsp;&nbsp;Warrants issued | $— | $5396 |
| &nbsp;&nbsp;&nbsp;Amendment fee added to principal of loan | $1286 | $978 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

**PURPLE INNOVATION, INC.**

**Notes to Condensed Consolidated Financial Statements**

**(unaudited)**

**1. Organization**

The mission of Purple Innovation, Inc. (the "Company" or "Purple Inc.") is to deliver the greatest sleep ever invented.

The Company, collectively with its subsidiary Purple Innovation, LLC ("Purple LLC") is an omni-channel business that began as a digitally-native vertical brand founded on comfort product innovation with premium offerings, and have since expanded into brick & mortar stores as a true omni-channel brand. The Company offers a variety of innovative, branded and premium comfort products, including mattresses, pillows, cushions, bases, sheets and other products. The Company markets and sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

The Company was incorporated in Delaware on May 19, 2015, as a special purpose acquisition company under the name of Global Partnership Acquisition Corp ("GPAC"). On February 2, 2018, the Company consummated a transaction structured similar to a reverse recapitalization (the "Business Combination") pursuant to which the Company acquired a portion of the equity of Purple LLC. At the closing of the Business Combination (the "Closing"), the Company became the sole managing member of Purple LLC, and GPAC was renamed Purple Innovation, Inc.

As the sole managing member of Purple LLC, Purple Inc. through its officers and directors is responsible for all operational and administrative decision making and control of the day-to-day business affairs of Purple LLC without the approval of any other member.

**2. Summary of Significant Accounting Policies**

***Basis of Presentation and Principles of Consolidation***

The unaudited condensed consolidated financial statements include the accounts of Purple Inc., its controlled subsidiary Purple LLC, and Purple LLC's wholly owned subsidiary Advanced Comfort Technologies, Inc., dba Intellibed ("Intellibed"). All intercompany balances and transactions have been eliminated in consolidation. As of March 31, 2026, Purple Inc. held 99.85% of the common units of Purple LLC and Purple LLC Class B Unit holders held 0.15% of the common units in Purple LLC.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting and reflect the financial position, results of operations and cash flows of the Company. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The unaudited condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, reflect all adjustments (all of which were considered of normal recurring nature) considered necessary to present fairly the Company's financial results. The results of the three months ended March 31, 2026 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2026 or for any other interim period or other future year.

***Liquidity and Going Concern***

The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. In connection with the preparation of the unaudited condensed consolidated financial statements for the three months ended March 31, 2026, the Company conducted an evaluation as to whether there were conditions and events, considered in the aggregate, which raised substantial doubt as to its ability to continue as a going concern within one year after the date of the issuance of such financial statements.

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

The Company had cash and cash equivalents of approximately $25.0 million and an accumulated deficit of $655.8 million at March 31, 2026. The Company had a net loss of $30.5 million and net cash provided by operating activities and used in investing activities was $3.0 million and $2.0 million, respectively, for the three months ended March 31, 2026. The Company has a history of recurring net losses and cash used in operations, an accumulated deficit, and requiring additional capital to fund its operations.

The funds the Company has on hand and any follow-on capital, if needed, will be used to fund its operations and invest in the business to expand sales and marketing efforts, as well as to invest in innovation. As described below, management has implemented plans to both increase its revenues from the sales of its products and to achieve cost savings within the next year, sufficient to generate positive operating cash flow levels. However, the Company may be adversely impacted by uncertain market conditions and there can be no assurance that the Company will be successful in this regard. If such plans are not successful, the Company may need to raise additional capital in order to support operations and business initiatives. Access to additional capital is uncertain and not within the control of the Company. Accordingly, there is substantial doubt about the Company's ability to continue as a going concern.

The Company has taken a number of actions to increase cash flow and support its operations and strategies. In August 2024, the Company implemented the Restructuring Plan (as defined below) to consolidate manufacturing operations resulting in cost savings. The Company has realized and plans to continue to realize direct material cost savings by concentrating efforts on driving gross margin improvement through various methods such as selective pricing actions, continued mix shift towards the Restore and Rejuvenate collections, and by driving cost savings through supply chain initiatives and manufacturing efficiency. The Company has delivered direct material cost savings from its supplier diversification efforts, improved scrap and yield results from continuous improvements, and outbound freight costs reflect cost improvements along with improved delivery reliability. The Company has been successful in subleasing the two manufacturing facilities that were vacated as part of the Restructuring Plan. The Company has also taken additional cost-saving initiatives in 2025 and the beginning of 2026 to reduce headcount and streamline responsibilities and reporting structure. Further, management's plans include additional actions intended to improve liquidity and reduce costs, including a planned optimization of advertising spend, limiting the number of new store openings, efforts to mitigate tariff impacts by managing the country of origin, and other cost-saving initiatives. As disclosed in Note 10 - *Debt,* the Company has elected to have interest paid-in-kind and added to the principal amount of the loans under the Amended and Restated Credit Agreement and on March 24, 2026, the Company executed the Third Amendment to the Amended and Restated Credit Agreement (the "Third Amendment") with the Lenders to extend the maturity date of the Amended and Restated Credit Agreement from December 31, 2026 to April 30, 2027. The Company is currently evaluating potential strategic alternatives and opportunities to achieve additional liquidity through one or more future debt refinancings.

Additionally, in May 2025, the Company entered into an agreement with Mattress Firm, Inc. ("Mattress Firm"), a business unit of Somnigroup International, Inc. ("SGI") to expand its inventory of the Company's products across SGI's national store network from approximately 5,000 mattress slots to a minimum of 12,000 mattress slots (see Note 13 — *Commitments and Contingencies, SGI Commercial Arrangements).* The Company is now represented in Mattress Firm's full store network and with the recent launch of Purple Royale, the exclusive Luxe product for Mattress Firm, the Company has expanded to all 12,000 committed slots. The Company has also expanded into more Costco clubs in the fourth quarter of 2025.

The consolidated financial statements do not include any adjustments that may result from the outcome of these uncertainties.

***Revenue Recognition – Consideration Payable to Customers***

 ****

There have been no material changes to the Company's revenue recognition policies as described in the Company's Annual Report on Form 10-K, except for the following application of accounting guidance to certain arrangements with third-party manufacturers.

The Company enters into arrangements with third-party manufacturers, including manufacturers under common control with certain customers, to produce mattress products sold to those customers. The Company evaluates these arrangements to determine whether payments to such manufacturers represent consideration payable to a customer or payments for goods or services received, in accordance with ASC 606—*Revenue from Contracts with Customers.* For certain customer-specific or exclusive product arrangements, the Company has concluded that payments to a manufacturer under common control with a customer are economically linked to the underlying customer arrangement and represent consideration payable to that customer. Accordingly, revenue for these arrangements is presented net of payments made to the third-party manufacturers.

 ****

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

***Variable Interest Entities***

Purple LLC is a variable interest entity. The Company determined that it is the primary beneficiary of Purple LLC as it is the sole managing member and has the power to direct the activities most significant to Purple LLC's economic performance as well as the obligation to absorb losses and receive benefits that are potentially significant. At March 31, 2026, Purple Inc. had a 99.85% economic interest in Purple LLC and consolidated 100% of Purple LLC's assets, liabilities and results of operations in the Company's unaudited condensed consolidated financial statements contained herein. The holders of Class B Units of Purple LLC ("Class B Units") held 0.15% of the economic interest in Purple LLC as of March 31, 2026. For further discussion see Note 15 — *Stockholders' Equity*.

***Use of Estimates***

The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires the Company to establish accounting policies and to make estimates and judgments that affect the reported amounts of assets and liabilities and disclose contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. The Company regularly makes estimates and assumptions including, but not limited to, estimates that affect revenue recognition, accounts receivable and the allowance for credit losses, valuation of inventories, sales returns, warranty returns, impairment reviews of long-lived assets and definite-lived intangible assets, warrant liabilities, stock based compensation, the recognition and measurement of loss contingencies, the recognition and measurement of restructuring and related charges, estimates of current and deferred income taxes, deferred income tax valuation allowances, and amounts associated with the Company's tax receivable agreement with InnoHold, LLC ("InnoHold"). Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. Actual results could differ materially from those estimates.

***Segment Information***

The Company operates in one operating segment. This is consistent with the organizational structure and internal reporting evaluated regularly by the Company's Chief Executive Officer who is our chief operating decision maker ("CODM") when making operational decisions and allocating resources. For additional information regarding the Company's segment reporting, refer to Note 20 *– Segment Information and Concentrations*.

***Recent Accounting Pronouncements***

*Expense Disaggregation Disclosures*

In November 2024, the FASB issued ASU No. 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure of certain costs and expenses on an interim and annual basis in the notes to the consolidated financial statements. The prescribed cost and expense categories requiring disaggregated disclosures include purchases of inventory, employee compensation, depreciation and intangible asset amortization, along with certain other expense disclosures already required by GAAP that would need to be integrated within the new tabular disaggregated expense disclosures. Additionally, the amendments also require the disclosure of total selling expenses and an entity's definition of those expenses. The guidance is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The guidance is to be applied either (1) prospectively to financial statements issued for reporting periods after the effective date or (2) retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the potential impact this update will have on its expense disclosures in the notes to the consolidated financial statements.

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

*Accounting for Internal-Use Software*

In September 2025, the FASB issued ASU No. 2025-06, "Intangible - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software." The ASU removes all references to prescriptive and sequential software development stages. The ASU requires entities to begin capitalizing software costs when management authorizes and commits to funding the software project, and it is probable that the project will be completed and the software will be used for its intended purpose. The amendments in this ASU are effective for fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact this update will have on its consolidated financial statements and related disclosures.

*Accounting for Government Grants Received by Business Entities*

In December 2025, the FASB issued ASU 2025-10, "Accounting for Government Grants Received by Business Entities," to establish guidance on the recognition, measurement, and presentation of government grants received by business entities. This guidance is effective for annual periods beginning after December 15, 2028. Early adoption is permitted. The Company does not expect the adoption of this to have a significant impact on its consolidated financial statements.

**3. Restructuring, Impairment and Other Related Charges**

In August 2024, the Company initiated a restructuring plan to strategically realign the Company's focus on the achievement of operational efficiencies that are expected to improve profitability and provide for reinvesting in technology and marketing initiatives (the "Restructuring Plan"). The Company's Restructuring Plan includes the permanent closure of its Grantsville and Salt Lake City, Utah manufacturing facilities to consolidate mattress production in its Georgia plant, and a headcount reduction at the Company's Utah headquarters to drive additional operating efficiencies. The consolidation into the Georgia facility was finalized in December 2024 and the closure of the two Utah manufacturing facilities was completed in May 2025. The reduction in workforce at the Utah headquarters was completed in August 2024. All restructuring activities were completed in the third quarter of 2025.

The following table summarizes the restructuring, impairment and other related charges the Company recognized during the first quarter of 2025 in the unaudited condensed consolidated statement of operations (in thousands):

---

| | | | |
|:---|:---|:---|:---|
|  | **Cost of<br> Revenues** | **Restructuring,<br> Impairment<br> and Other<br> Related<br> Charges** | **Total** |
| Cash charges: |  |  |  |
| &nbsp;&nbsp;&nbsp;Employee-related costs | $— | $171 | $171 |
| &nbsp;&nbsp;&nbsp;Other costs | 688 | 1154 | 1842 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash charges | 688 | 1325 | 2013 |
| Non-cash charges: |  |  |  |
| &nbsp;&nbsp;&nbsp;Accelerated depreciation | 230 |  | 230 |
| &nbsp;&nbsp;&nbsp;Write-down of long-lived assets |  | 635 | 635 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-cash charges | 230 | 635 | 865 |
| Total restructuring, impairment and other related charges | $918 | $1960 | $2878 |

---

Accelerated depreciation primarily represents $0.2 million of increased depreciation expense associated with shortening the useful lives of the production equipment at the two Utah manufacturing facilities that were closed to reflect the remaining period these assets will remain in service.

The $0.6 million write-down of long-lived assets represents the write-down to salvage value of other property and equipment located at the two Utah manufacturing facilities that were closed.

The $2.0 million of cash charges relates to costs incurred in shutting down and transitioning operations from the two Utah manufacturing facilities that were closed.

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

**4. Fair Value Measurements**

The Company uses the fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:

Level 1—Quoted market prices in active markets for identical assets or liabilities;

Level 2—Significant other observable inputs (i.e., quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable, such as interest rate and yield curves, and market-corroborated inputs); and

Level 3—Unobservable inputs in which there is little or no market data, which require the reporting unit to develop its own assumptions.

The classification of fair value measurements within the established three-level hierarchy is based upon the lowest level of input that is significant to the measurements. Financial instruments, although not recorded at fair value on a recurring basis include cash, cash equivalents, accounts receivables, accounts payable, and the Company's debt obligations. The carrying amounts of cash, cash equivalents, accounts receivable and accounts payable approximate fair value because of the short-term nature of these accounts.

The estimated fair value of the Company's related party debt is based on Level 2 and Level 3 inputs. Level 2 inputs include observable inputs such as market-based expectations for interest rates, credit risk and volatility. The unobservable Level 3 inputs are associated with the required rate of return for the security implied by the various issuances of debt bundled with warrants, which were valued using a Monte Carlo model and the timing and probability of a warrant reprice event, like a strategic alternative transaction. The estimated fair value of the Company's related party debt was $112.7 million and $72.6 million as of March 31, 2026 and 2025.

The warrant liabilities (see Note 11 — *Warrant Liabilities* for more information) are Level 3 instruments and use internal models to estimate fair value using certain significant unobservable inputs which require determination of relevant inputs and assumptions. Accordingly, changes in these unobservable inputs may have a significant impact on fair value. Significant inputs, certain of which are unobservable, include risk free interest rate, expected average life, expected dividend yield, expected volatility and the timing and probability of a warrant reprice event. These Level 3 liabilities generally decrease (increase) in value based upon an increase (decrease) in risk free interest rate and expected dividend yield. Conversely, the fair value of these Level 3 liabilities generally increases (decreases) in value if the expected average life or expected volatility were to increase (decrease).

The following table summarizes the Company's total Level 3 liability activity for the three months ended March 31, 2026 (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Warrants** | **Total<br> Level 3<br> Liabilities** |
| Fair value as of December 31, 2025 | $16150 | $16150 |
| Change in valuation inputs<sup>(1)</sup> | 6958 | 6958 |
| Fair value as of March 31, 2026 | $23108 | 23108 |

---

(1) Changes in valuation inputs are recognized as the change in fair value – warrant liabilities in the unaudited condensed consolidated statement of operations.

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

**5. Revenue from Contracts with Customers**

The Company markets and sells its products through direct-to-consumer e-commerce channels, Purple showrooms, retail brick-and-mortar wholesale partners, and third-party online retailers. Revenue is recognized when the Company satisfies its performance obligations under the contract which involves transferring the promised products to the customer, subject to shipping terms.

*Disaggregated Revenue*

The Company classifies revenue as either direct-to-consumer ("DTC") or wholesale revenue. DTC revenues include the e-commerce channel which sells directly to consumers who purchase online, through the contact center, and through online marketplaces and the showrooms channel that sells directly to consumers who purchase at a Purple showroom location. The wholesale channel includes all product sales to the Company's retail brick and mortar and online wholesale partners where consumers make purchases at their retail locations or through their online channels.

The following tables present the Company's revenue disaggregated by sales channel (in thousands):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br> March 31,** | **Three Months Ended<br> March 31,** |
| <br>**Sales Category** | **2026** | **2025** |
| e-commerce | $40596 | $45397 |
| Showrooms | 18847 | 17986 |
| Wholesale | 36287 | 40788 |
| &nbsp;&nbsp;&nbsp;Revenues, net | $95730 | $104171 |

---

*Contract Balances*

Payments for the sale of products through the direct-to-consumer e-commerce channel, Purple showrooms and our contact center are collected at point of sale in advance of shipping the products. The amounts received for unshipped products are recorded as customer prepayments. Customer prepayments totaled $4.7 million and $5.3 million at March 31, 2026 and December 31, 2025, respectively. During the three months ended March 31, 2026, the Company recognized all of the revenue that was deferred in customer prepayments at December 31, 2025.

**6. Inventories**

Inventories consisted of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| Raw materials | $21556 | $23420 |
| Work-in-process | 6205 | 6355 |
| Finished goods | 30327 | 29950 |
| &nbsp;&nbsp;&nbsp;Inventories | $58088 | $59725 |

---

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

**7. Property and Equipment, Net**

Property and equipment, net consisted of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| Equipment | $86764 | $80999 |
| Equipment in progress | 3146 | 7218 |
| Leasehold improvements | 58867 | 58862 |
| Furniture and fixtures | 30422 | 30744 |
| Office equipment | 1624 | 1624 |
| Total property and equipment | 180823 | 179447 |
| Accumulated depreciation | (104990) | (101486) |
| &nbsp;&nbsp;&nbsp;Property and equipment, net | $75833 | $77961 |

---

Equipment in progress reflects equipment, primarily related to mattress manufacturing, which is being constructed and was not in service at March 31, 2026 or December 31, 2025. Interest capitalized on borrowings during the active construction period of major capital projects totaled $0.1 million and $0.2 million during the three months ended March 31, 2026 and 2025, respectively. Depreciation expense was $3.8 million and $4.2 million during the three months ended March 31, 2026 and 2025, respectively. Included in depreciation expense for the three months ended March 31, 2025 was $0.2 million related to accelerated depreciation associated with the Restructuring Plan. See Note 3— *Restructuring and Impairment Charges* for further discussion*.*

**8. Leases**

The Company leases its manufacturing and distribution facilities, corporate offices, Purple showrooms and certain equipment under non-cancelable operating leases with various expiration dates through 2036. The Company's office and manufacturing leases provide for initial lease terms up to 16 years, while Purple showrooms have initial lease terms of up to 10 years. Certain leases may contain options to extend the term of the original lease. The exercise of lease renewal options is at the Company's discretion. Any lease renewal options are included in the lease term if exercise is reasonably certain at lease commencement. The Company also leases vehicles and other equipment under both operating and finance leases with initial lease terms of three to five years. The ROU asset for finance leases totaled $0.7 million and $0.6 million at March 31, 2026 and December 31, 2025, respectively.

The following table presents the Company's lease costs (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br> March 31,** | **Three Months Ended<br> March 31,** |
|  | **2026** | **2025** |
| Operating lease costs | $4540 | $4780 |
| Variable lease costs | 1126 | 1042 |
| Short-term lease costs | 110 | 42 |
| &nbsp;&nbsp;&nbsp;Total lease costs | $5776 | $5864 |

---

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

The table below reconciles the undiscounted cash flows for each of the first five years and total remaining years to the operating lease liabilities recorded on the unaudited condensed consolidated balance sheet at March 31, 2026 (in thousands):

---

| | |
|:---|:---|
| 2026 (excluding the three months ended March 31, 2026)<sup>(1)</sup> | $14504 |
| 2027 | 21008 |
| 2028 | 20688 |
| 2029 | 17880 |
| 2030 | 12072 |
| Thereafter | 25297 |
| &nbsp;&nbsp;&nbsp;Total operating lease payments | 111449 |
| Less – lease payments representing interest | (19550) |
| &nbsp;&nbsp;&nbsp;Present value of operating lease payments | $91899 |

---

(1) Amount consists of $14.8 million of undiscounted cash flows offset by $0.3 million of tenant improvement allowances which are expected to be fully utilized in fiscal 2026.

As of March 31, 2026 and December 31, 2025, the weighted-average remaining term of operating leases was 6.1 years and 6.3 years, respectively, and the weighted-average discount rate of operating leases was 6.90% and 6.79%, respectively.

The following table provides supplemental information related to the Company's unaudited condensed consolidated statement of cash flows for the three months ended March 31, 2026 and 2025 (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br> March 31,** | **Three Months Ended<br> March 31,** |
|  | **2026** | **2025** |
| Cash paid for amounts included in present value of operating lease liabilities <sup>(1)</sup> | $5503 | $4099 |
| Right-of-use assets obtained in exchange for operating lease liabilities | 1668 | 7192 |

---

(1) Operating cash flows paid for operating leases are included within the change in operating leases, net within the unaudited condensed consolidated statement of cash flows offset by non-cash ROU asset amortization and lease liability accretion.

**9. Other Current Liabilities**

Other current liabilities consisted of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| Accrued sales returns | $3522 | $4492 |
| Accrued sales tax and use tax | 1669 | 2264 |
| Asset retirement obligation | 1132 | 1132 |
| Insurance financing | 470 | 1676 |
| Other | 804 | 775 |
| &nbsp;&nbsp;&nbsp;Total other current liabilities | $7597 | $10339 |

---

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

**10. Debt**

Debt consisted of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| Related party loan | $132487 | $126697 |
| Less: unamortized debt issuance costs | (13288) | (15392) |
| &nbsp;&nbsp;&nbsp;Total related party debt | 119199 | 111305 |

---

***2024 Credit Agreement***

On January 23, 2024, Purple LLC, Purple Inc. and Intellibed (collectively, the "Loan Parties") entered into an amended and restated credit agreement (the "Amended and Restated Credit Agreement"), which amended and restated the then existing term loan agreement ("Term Loan Agreement"), with Coliseum Capital Partners ("CCP") and other lenders (collectively, the "Lenders") and Delaware Trust Company, as administrative agent. The Lenders agreed to assume the Loan Parties' obligations under the Term Loan Agreement and refinance their existing obligations. A term loan in the amount of $61.0 million (the "Related Party Loan") was funded by the Lenders that repaid in full the $25.0 million of term loans outstanding, repaid in full the $5.0 million of asset based lending loans outstanding, paid fees, premiums and expenses incurred in connection with this transaction, and provided net proceeds to the Company (after payments of outstanding debt, unpaid accrued interest and expenses) equal to approximately $27.0 million. Interest on the Related Party Loan is payable each month and the principal outstanding matures and is due on December 31, 2026. The Company has elected for interest to be capitalized and added to the principal amount of the loan. The Related Party Loan bears interest at a rate equal to (i) the secured overnight financing rate as administered by the Federal Reserve Bank of New York plus 0.10%, with a floor of 3.5% per annum, plus (ii) 8.25% per annum (or, if Purple LLC elects to pay interest in kind to reduce it cash obligations, 10.25% per annum). Any prepayments of principal on or after August 7, 2024 but before August 7, 2025 are subject to a prepayment penalty of 1.25%, and any prepayments of principal on or after August 7, 2025 are subject to a prepayment penalty of 2.50%. The Loan Parties may request an additional term loan from the Lenders in an aggregate amount not to exceed $19.0 million on terms requested by them to the extent agreed to by the Lenders at their discretion. The Amended and Restated Credit Agreement also removed restrictions and requirements typically associated with an asset-based loan.

In connection with the Amended and Restated Credit Agreement, the Company issued 20.0 million warrants (the "2024 Warrants") to the Lenders (see Note 11 – *Warrant Liabilities*) and incurred additional fees and expenses of $3.5 million that were recorded as debt issuance costs in the first quarter of 2024 and are being amortized over the life of the loan.

 ****

The Amended and Restated Credit Agreement granted a security interest to the Lenders in substantially all of the assets (subject to certain limited exceptions) of the Loan Parties to secure the Loan Parties' loans and other obligations under the Amended and Restated Credit Agreement, including a security interest in the intellectual property owned by the Loan Parties.

 ****

The Loan Parties (other than Purple LLC) provided an unconditional guaranty of the payment of all obligations and liabilities of Purple LLC under the Amended and Restated Credit Agreement.

The Amended and Restated Credit Agreement also provides for standard indemnification of the Lenders and contains representations, warranties and certain covenants of the Loan Parties. While any amounts are outstanding under the Amended and Restated Credit Agreement, the Loan Parties are subject to a number of affirmative and negative covenants, including covenants regarding dispositions of property, investments, forming or acquiring subsidiaries, business combinations or acquisitions, incurrence of additional indebtedness and transactions with affiliates, among other customary covenants. The Loan Parties are also restricted from paying dividends or making other distributions or payments on their capital stock, subject to limited exceptions. As of March 31, 2025, the Company was in compliance with all covenants under the Amended and Restated Credit Agreement.

***2025 Amendment***

On March 12, 2025, the Loan Parties, entered into the First Amendment to the Amended and Restated Credit Agreement (the "2025 Amendment" and the Amended and Restated Credit Agreement as so amended, the "Amended A&R Credit Agreement") with CCP and Blackwell Partners LLC – Series A ("Blackwell") (collectively the "2025 Lenders"), which amends the Amended and Restated Credit Agreement. The 2025 Amendment, among other things, provides for an increase in the initial principal amount of the Related Party Loan by $19.0 million (the "First Incremental Loan") from an initial Related Party Loan principal amount of $61.0 million to an initial aggregate principal amount of $80.0 million, pursuant to Section 2.18 of the Amended and Restated Credit Agreement, and allows the Loan Parties to request one or more additional term loans from the 2025 Lenders in an initial aggregate principal amount not to exceed $20.0 million on terms to be agreed to by the parties and subject to the approval of the Required Lenders (as defined in the Amended and Restated Credit Agreement). The First Incremental Loan will bear interest at the same rate as the Initial Loan (as defined in the Amended and Restated Credit Agreement), which may be paid in cash or in kind at the Company's option.

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

The 2025 Amendment also provides that (i) the First Incremental Loan shall be senior in right of repayment to the Related Party Loan and (ii) in any voluntary or mandatory prepayment in part or in full of the First Incremental Loan for any reason, the Company will be required to pay an amount equal to the greater of (i) the Make-Whole Premium (as defined below) and (ii) 2.50% of the aggregate principal amount of the First Incremental Loan so prepaid, replaced or assigned. The "Make-Whole Premium" is determined as follows: on the date of prepayment, the excess of (A) (x) 100% of the principal amount of such First Incremental Loan, plus (y) the present value at such date of all remaining scheduled interest payments due on such First Incremental Loan from the prepayment date through the maturity date, assuming that all such interest accrues at the Make-Whole Premium Rate (as defined in the 2025 Amendment), computed using a discount rate equal to the Treasury Rate as of such prepayment date plus 50 basis points, over (B) the principal amount of such First Incremental Loan on such prepayment date.

The 2025 Amendment requires prepayment from certain amounts of proceeds received by the Company related to asset dispositions, equity issuances, incurrence of indebtedness, and extraordinary receipts. Additionally, upon an event of default, the 2025 Lenders may declare all or any portion of the term loan then outstanding to be accelerated and due and payable, immediately, including the prepayment premium. The Company determined that these features qualify as a derivative and must be bifurcated from the debt, but such value is de minimis. The Company will reassess whether the derivative has more than a de minimis value at each reporting period.

The 2025 Amendment also includes contingent interest upon an event of default at a rate of 2%. Certain non-credit related factors qualify as a derivative and must be bifurcated from the debt, but such value is de minimis.

In addition, the Company also paid (i) an amendment fee equal to 2% of the outstanding principal and accrued and unpaid interest under the Related Party Loan held by the 2025 Lenders, paid in kind and (ii) a 2% work fee of the initial aggregate principal amount of the First Incremental Loan paid to the 2025 Lenders, deducted from the proceeds at closing. Total fees and expenses of $2.1 million were recorded as a debt discount upon issuance of the Incremental Loan and are being amortized over the life of the loan.

In connection with the 2025 Amendment, the Company issued to the 2025 Lenders, warrants (the "2025 Warrants") to purchase 6.2 million shares of the Company's Class A common stock at a price of $1.50 per share, subject to certain adjustments (see Note 11 – *Warrant Liabilities*). These 2025 Warrants include full-ratchet anti-dilution protections, subject to a floor of $0.6979 with respect to adjustments to the exercise price and expire on March 12, 2035. The 2025 Warrants had a fair value of $5.4 million upon issuance and were recorded as a debt discount upon issuance of the Incremental Loan and is being amortized over the life of the loan.

The 2025 Amendment was evaluated and determined to be a modification of debt as the effective borrowing rate was not reduced, therefore the 2025 Lenders did not grant a concession, and the 2025 Amendment terms were not substantially different from the Amended and Restated Credit Agreement.

***Second 2025 Amendment***

On May 2, 2025, the Loan Parties entered into a Second Amendment to the Amended and Restated Credit Agreement (the "Second 2025 Amendment") with the 2025 Lenders, which amends the Amended A&R Credit Agreement. The Second 2025 Amendment, among other things, provides for a commitment increase in the initial principal amount of the senior secured term loan facility by $20.0 million (the "Second Incremental Loan") from an aggregate principal amount of up to $80.0 million (the "Existing Loan") to an initial aggregate principal amount of up to $100.0 million (the "Loan") and allows the Loan Parties to request one or more additional term loans from the Lenders in an initial aggregate principal amount not to exceed $20.0 million on terms to be agreed to by the parties and subject to the approval of the Required Lenders (as defined in the Amended A&R Credit Agreement). The Second Incremental Loan will bear interest at the same rate as the Existing Loan, which may be paid in cash or in kind at the Company's option.

The Second 2025 Amendment also provides that (i) the Second Incremental Loan shall be senior in right of repayment to the initial $61.0 million loan under the Amended and Restated Credit Agreement and pari passu with the First Incremental Loan and (ii) in any voluntary or mandatory prepayment in part or in full of the Second Incremental Loan for any reason, the Company will be required to pay an amount equal to the greater of (a) the Make-Whole Premium (as defined below) and (b) 2.5% of the aggregate principal amount of the Second Incremental Loan so prepaid, replaced or assigned. The "Make-Whole Premium" is determined as follows: on the date of prepayment, the excess of (A) (x) 100% of the principal amount of such Second Incremental Loan, plus (y) the present value at such date of all remaining scheduled interest payments due on such Second Incremental Loan from the prepayment date through the maturity date, assuming that all such interest accrues at the Make-Whole Premium Rate (as defined in the Second 2025 Amendment), computed using a discount rate equal to the Treasury Rate as of such prepayment date plus 50 basis points, over (B) the principal amount of such Second Incremental Loan on such prepayment date.

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

In addition, the Company also paid (i) an amendment fee equal to 0.25% of the outstanding principal and accrued and unpaid interest under the Existing Loan held by the Lenders, paid in kind to the 2025 Lenders, (ii) a work fee equal to 0.1% of the outstanding principal and accrued and unpaid interest under the Existing Loan, paid in cash to the Required Lenders, (iii) a waiver fee, to induce the Required Lenders to waive certain preemptive and right of first refusal rights, equal to 0.15% of the outstanding principal and accrued and unpaid interest under the Existing Loan, paid in cash to the Required Lenders, and (iv) a commitment fee equal to $0.2 million, paid in cash to the Required Lenders.

In connection with the Second 2025 Amendment, the Company issued to the 2025 Lenders, warrants (the "2025 Additional Warrants") to purchase 6.6 million shares of the Company's Common Stock at a price of $1.50 per share, subject to certain adjustments (see Note 11 – *Warrant Liabilities*). These 2025 Additional Warrants include full-ratchet anti-dilution protections, subject to a floor of $0.6979 with respect to adjustments to the exercise price and expire on March 12, 2035. The 2025 Additional Warrants had a fair value of $5.4 million upon issuance and were recorded as a debt discount upon issuance of the Incremental Loan and is being amortized over the life of the loan.

The Second 2025 Amendment was evaluated and determined to be a modification of debt since the 2025 Lenders did not grant a concession, as the effective borrowing rate was not reduced, and the 2025 Amendment terms were not substantially different from the Amended and Restated Credit Agreement.

 ****

***Third Amendment to the Amended A&R Credit Agreement***

On March 24, 2026, the Loan Parties entered into a Third Amendment to the Amended A&R Credit Agreement with the Lenders, which revised the maturity date under the Amended A&R Credit Agreement from December 31, 2026, to April 30, 2027 and waived certain requirements and events of default relating to the going concern qualification in our December 31, 2025 financial statements. In connection with the Third Amendment, the Loan Parties agreed to pay to the Lenders an amendment fee in the aggregate amount of $1.6 million, equal to 1.25% pro rata based on each Lender's outstanding principal amount (the "Amendment Fee"). Of the Amendment Fee, approximately $1.3 million was payable-in-kind by adding such amount to the 2025 Lenders' outstanding principal amount. The remaining $0.3 million of the Amendment Fee was paid in cash to the other lenders. In connection with the Third Amendment, the Loan Parties also agreed to reimburse the 2025 Lenders for certain expenses in the amount of $0.3 million.

Pursuant to the Third Amendment to the Amended A&R Credit Agreement, the Loan Parties waived certain requirements and events of default relating to the going concern qualification in our December 31, 2025 financial statements. Accordingly, the Company is in compliance as of March 31, 2026, with all covenants under the Amended A&R Credit Agreement.

The Company determined that it was experiencing financial difficulty and that the extension represented a concession granted by the Lenders as the effective borrowing rate was reduced. Accordingly, the Company accounted for the Third Amendment as a troubled debt restructuring. Since the undiscounted future cash payments were more than the carrying amount of the existing instrument, no gain was recognized. The impact of the revised terms, including the extension and associated amendment fee, has been reflected in the carrying amount of the debt and is being recognized through interest expense prospectively using a revised effective interest rate.

The Company has elected to have interest paid-in-kind and added to the principal amount of the loans. Interest expense under the Related Party Loan, the First Incremental Loan and the Second Incremental Loan for the three months ended March 31, 2026 and 2025 consisted of paid-in-kind interest of $4.5 million and $2.8 million, respectively and debt issuance cost amortization of $3.7 million and $2.1 million, respectively. The effective interest rate was 14.03% and 14.68% for the three months ended March 31, 2026 and 2025, respectively.

**11. Warrant Liabilities**

On January 23, 2024, in connection with the Amended and Restated Credit Agreement, the Company issued 20.0 million 2024 Warrants to the Lenders, on March 12, 2025, in connection with the 2025 Amendment, the Company issued 6.2 million 2025 Warrants to the 2025 Lenders, on May 2, 2025, in connection with the Second 2025 Amendment, the Company issued 6.6 million 2025 Additional Warrants to the 2025 Lenders, and on May 2, 2025, in connection with the SGI Agreements (as defined below), the Company issued to SGI warrants to purchase 8.0 million shares of the Company's Common Stock (the "SGI Warrants," collectively, the "Warrants"). Each Warrant entitles the registered holder to purchase one share of the Company's Class A common stock at a price of $1.50 per share, subject to adjustment. While the Warrants are exercisable, the Company may call the Warrants for redemption in whole and not in part at any time at a price of $0.01 per share of Class A common stock issuable upon exercise of the Warrants upon not less than 45 days' prior written notice of redemption to each holder, provided that this redemption right is only available if the reported last sale price of the Class A common stock equals or exceeds $24.00 per share on each of 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the holders. The Warrants will expire on the 10-year anniversary of issuance, or earlier upon redemption. The holders do not have the rights or privileges of holders of Class A common stock or any voting rights until they exercise their Warrants. After the issuance of shares of Class A common stock upon exercise of the Warrants, each holder will be entitled to one vote for each share of Class A common stock held on all matters to be voted on by stockholders generally. A holder of the Warrants will not have the right to exercise its Warrants, to the extent that after giving effect to such exercise, the holder (together with its affiliates) would beneficially own in excess of 49.9% of the shares of Class A common stock outstanding immediately after giving effect to such exercise. The Warrants contain a repurchase provision which, upon an occurrence of a fundamental transaction as defined in the warrant agreement, could give rise to an obligation of the Company to pay cash to the warrant holders. In addition, other provisions may lead to a reduction in the exercise price of the Warrants. The Company determined the fundamental transaction provisions require the Warrants to be accounted for as a liability at fair value on the date of the transaction, with changes in fair value recognized in earnings in the period of change. As a result, the liability for these Warrants was recorded at fair value on the date of issuance with the offset included in debt issuance costs. This liability is subsequently re-measured to fair value at each reporting date or exercise date with changes in the fair value included in earnings.

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

The Company used a Monte Carlo Simulation model to determine the fair value of the liability associated with the Warrants. The model used key assumptions and inputs, such as exercise price, fair market value of common stock, risk free interest rate, warrant life, expected volatility and the probability of a warrant re-price event. The following are the assumptions used in calculating fair value of the Warrants:

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br> **2026** | **December 31,**<br> **2025** |
| Trading price of common stock on measurement date | $0.66 | $0.69 |
| Exercise price | $1.50 | $1.50 |
| Risk free interest rate | 4.08 – 4.15% | 3.95 – 4.03% |
| Warrant life in years | 7.82 – 8.95 | 8.06 – 9.20 |
| Expected volatility | 87.0% | 88.0% |
| Expected dividend yield |  |  |
| Probability of an event causing a warrant re-price | 40.0% | 70.0% |
| Estimated date of event causing a warrant re-price | March 2027 | May 2026 |

---

The Warrants had a fair value of $23.1 million as of March 31, 2026. The Company recognized a $7.0 million expense in the unaudited condensed consolidated statement of operations for the three months ended March 31, 2026 related to an increase in the fair value of the Warrants outstanding at the end of the period compared to the fair value of the Warrants at the end of 2025. The Company recorded a de minimis gain for the three months ended March 31, 2025 related to the increase in fair value of the Warrants outstanding at the end of the period.

**12. Other Long-Term Liabilities**

Other long-term liabilities consist of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| Asset retirement obligations | $1176 | $1160 |
| Other | 453 | 604 |
| Total other long-term liabilities | $1629 | $1764 |

---

**13. Commitments and Contingencies**

***Warranty Liabilities***

The Company provides a limited warranty on most of the products it sells. The estimated warranty return costs associated with products sold through DTC channels are expensed at the time of sale and included in cost of revenues. The estimated warranty return costs associated with products sold through the wholesale channel are recorded at the time of sale and included as an offset to net revenues. Estimates for DTC warranty costs are based primarily on historical warranty claims, estimated warranty costs and the estimate warranty claim rate. Estimates for wholesale warranty costs are based primarily on the historical warranty claim amounts and the estimated claim rate and may be adjusted for any current or expected trends as appropriate. Actual warranty claim costs could differ from these estimates. The Company regularly assesses and adjusts the estimate of accrued warranty claims by updating claims rates for actual trends and projected claim costs. The Company classifies estimated warranty costs expected to be paid beyond a year as a long-term liability. The Company has accrued $27.5 million and $26.7 million in estimated future warranty costs as of March 31, 2026 and December 31, 2025, respectively.

***Chief Executive Officer Cash Bonus Award***

On January 26, 2024, the Company's board of directors (the "Board") approved an amendment to the Chief Executive Officer's employment agreement. Under the amendment, the Company agreed that, among other things, the Chief Executive Officer will be eligible to earn a cash payment of up to $5.0 million, less tax and other required withholdings, based on the volume weighted average price per share of the Company's Class A common stock on NASDAQ during the period from March 16, 2026 through June 30, 2026 subject to his continued employment with the Company. The amount earned will be payable in quarterly installments commencing with the first payroll period following June 30, 2026. The Company determined the provisions surrounding the future bonus payment require it to be accounted for as a liability at fair value on the date of the transaction, with changes in fair value recognized in earnings in the period of change. The Company recorded a de minimis compensation expense reduction in the unaudited condensed consolidated statement of operations for the three months ended March 31, 2026 and 2025 related to this future bonus payment.

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

***Senior Leadership Team Special Recognition Bonus***

On January 26, 2024, the Board unanimously approved a special recognition bonus payment to certain members of the Company's senior leadership team. The bonus was awarded to incentivize retention and continued engagement with the Company during these challenging times in the bedding industry. Each participant is eligible to earn a special recognition bonus payment equal to 15 months of their regular salary. The special recognition bonus payment is paid as follows, subject to the employee's continued employment with the Company: 10% was paid in August 2024, 20% was paid in February 2025, and the remaining 70% was to be paid in August 2025. Certain members of the Company's senior leadership team agreed to postpone their August 2025 payment until January 2026 for a 15% premium on the amount that was due to be paid in August 2025. Related to this bonus payment, the Company recorded no compensation expense for the three months ended March 31, 2026 and a de minimis compensation expense for the three months ended March 31, 2025 in the unaudited condensed consolidated statement of operations.

***Long-Term Incentive Cash Bonus Awards***

 

On July 17, 2025, the Board unanimously approved a long-term incentive cash award to those employees eligible to participate in the Company's 2017 Plan. The incentive award payment is based on a combination of time-based payments over a three-year period and performance-based payments paid in three years if certain financial performance targets are met.

On June 20, 2024, the Board unanimously approved a performance long-term incentive cash award to those employees eligible to participate in the Company's 2017 Plan. The incentive award payment is based on a performance goal of the volume weighted average price per share of the Company's Common Stock on NASDAQ on March 31, 2027. The Company determined the provisions surrounding the performance cash long-term incentive award require it to be accounted for as a liability at fair value at each reporting period, with changes in fair value recognized in earnings in the period of change.

The Company recorded a de minimis amount of compensation expense in the unaudited condensed consolidated statement of operations for the three months ended March 31, 2026 and 2025 related to these future award payments.

***Rights of Securities Holders***

On January 23, 2024, in connection with the issuance of the 2024 Warrants, the Company entered into an amended and restated registration rights agreement with holders of the Warrants (the "Holders"), providing for the registration under the Securities Act of 1933, as amended, of the 2024 Warrants, the shares issuable upon the exercise of the 2024 Warrants and Common Stock held by the Holders as of such date, subject to customary terms and conditions.

On March 12, 2025 in connection with the issuance of the 2025 Warrants, the Company entered into a Second Amended and Restated Registration Rights Agreement (the "Registration Rights Agreement") with the Holders, providing for the registration of the 2025 Warrants, the shares of Common Stock issuable upon the exercise of the Warrants, and the Common Stock held by the Holders as of such date (the "Registrable Securities").

On May 2, 2025 in connection with the issuance of the 2025 Additional Warrants, the Company entered into a Third Amended and Restated Registration Rights Agreement (the "Third Amended Registration Rights Agreement") with the Holders, providing for the registration under the Securities Act of the 2025 Additional Warrants, the shares issuable upon the exercise of the 2025 Additional Warrants, other warrants held by the Holders (and shares issuable upon exercise thereof) and the Common Stock held by the Holders as of such date (the "2025 Additional Registrable Securities"), subject to customary terms and conditions.

On May 2, 2025 in connection with the issuance of the SGI Warrants, the Company entered into a Registration Rights Agreement (the "SGI Registration Rights Agreement" and collectively with the 2025 Registration Rights Agreement and the Third Amended Registration Rights Agreement, the "Registration Rights Agreements") with SGI, providing for the registration under the Securities Act of the SGI Warrants, the shares issuable upon the exercise of the SGI Warrants, and the Common Stock held by SGI as of such date (the "SGI Registrable Securities" and collectively with the 2025 Registrable Securities and 2025 Additional Registrable Securities, the "Registrable Securities"), subject to customary terms and conditions.

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

The Registration Rights Agreements entitle the investors party thereto to demand registration of the Registrable Securities and also to piggyback on the registration of Company securities by the Company and other Company securityholders. The Company will be responsible for the payment of the Holders' expenses in connection with any offering or sale of Registrable Securities, including underwriting discounts or selling commissions, placement agent or broker fees or similar discounts, commissions or fees relating to the sale of certain Registrable Securities.

The registration statement filed on May 23, 2025, which registered the Registrable Securities, was declared effective by the SEC on May 30, 2025.

***SGI Commercial Arrangements***

On May 2, 2025, the Company entered into a Second Amendment to Master Retailer Agreement (the "MRA Amendment") with Mattress Firm, a business unit of SGI, which provides that SGI, through its Mattress Firm stores, will expand its inventory of the Company's products across its national store network from approximately 5,000 mattress slots to a minimum of 12,000 mattress slots. The agreement includes a $3.5 million fee to be paid by the Company to reimburse Mattress Firm for certain costs in transitioning to the product placement required by the agreement. The fee is accounted for under the provisions of ASC 606—*Revenue from Contracts with Customers* as consideration payable to a customer as a reduction of revenue over the life of the contract and is included in accrued rebates and allowances on the audited consolidated balance sheets. The Company recorded $0.3 million as a reduction of revenue in the unaudited condensed consolidated statement of operations for the three months ended March 31, 2026.

Also on May 2, 2025, the Company entered into an Amended and Restated Master Vendor Supply and Services Agreement (the "Sherwood Agreement" and together with the MRA Amendment the "SGI Agreements") with Tempur Sherwood, LLC, a subsidiary of Tempur Sealy. The Sherwood Agreement provides that Tempur Sherwood, LLC will have the exclusive right to assemble certain product lines, such as Purple Royale, that the Company sells to Mattress Firm. The SGI Agreements expire on December 31, 2027. Revenue for certain product arrangements is presented differently depending on the nature of the underlying manufacturing relationships and the application of ASC 606—*Revenue from Contracts with Customers*. Under the guidance, payments to Tempur Sherwood, LLC are evaluated to determine whether they are economically linked to the underlying customer arrangement. The Company has concluded that payments to Tempur Sherwood, LLC are economically linked to the Mattress Firm MRA Amendment and therefore represent consideration payable to a customer. As a result of the Purple Royale launch, these payments are recorded as a reduction of revenue, and revenue is presented on a net basis. The Company recorded $4.9 million in consideration paid to Tempur Sherwood, LLC as a reduction of revenue in the unaudited condensed consolidated statement of operations for the three months ended March 31, 2026.

In connection with the SGI Agreements, the Company issued to SGI the SGI Warrants to purchase 8.0 million shares of the Company's Class A common stock at a strike price of $1.50 per share. The SGI Warrants include full-ratchet anti-dilution protections, subject to a floor of $0.6979 with respect to adjustments to the exercise price and expire on March 12, 2035. The Company determined the warrants are required to be accounted for as a liability at the fair value of $6.5 million on the date of the transaction (see Note 11 – *Warrant Liabilities*). The fair value of the warrants on the date of the transaction is accounted for under the provisions of ASC 606—*Revenue from Contracts with Customers* and deemed to be consideration payable to a customer as a reduction of revenue over the life of the contract. The Company recorded $0.6 million as a reduction of revenue in the unaudited condensed consolidated statement of operations for the three months ended March 31, 2026.

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

***Non-Income Related Taxes***

The U.S. Supreme Court ruling in *South Dakota v. Wayfair, Inc.*, No.17-494, reversed a longstanding precedent that remote sellers are not required to collect state and local sales taxes. The Company cannot predict the effect of these and other attempts to impose sales, income or other taxes on e-commerce. The Company currently collects and reports on sales tax in all states in which it does business. However, the application of existing, new or revised taxes on the Company's business, in particular, sales taxes, value-added tax and similar taxes would likely increase the cost of doing business online and decrease the attractiveness of selling products over the internet. The application of these taxes on the Company's business could also create significant increases in internal costs necessary to capture data and collect and remit taxes. There have been, and will continue to be, substantial ongoing costs associated with complying with the various indirect tax requirements in the numerous markets in which the Company conducts or will conduct business.

***Legal Proceedings***

On December 16, 2022, Purple's founders filed a complaint against Purple Inc. in the Fourth Judicial District Court in the State of Utah. In that suit, the plaintiffs alleged that they each entered into employment agreements with Purple LLC in February 2018. The plaintiffs contended that certain corporate transactions reduced their "ownership interest and voting power in Purple" and that, as a result, they should have continued to be paid a salary when they retired from Purple LLC. The plaintiffs calculated that they were each owed "no less than $500,000" in unpaid salary. In October 2023, the Court granted Purple Inc.'s motion and ordered that the claims brought by the plaintiffs be dismissed in full, with prejudice. The Court entered a final judgment dismissing the case in January 2024. The plaintiffs appealed. After oral arguments, on April 3, 2025, the Utah Court of Appeals ordered the case return to the District Court for further fact finding. The Utah Supreme Court declined to hear the case, sending back for further action at the trial court that we expect will continue throughout 2026. The Company maintains insurance to cover the costs of defending against claims of this nature and intends to continue to vigorously defend against these claims in the course of the plaintiffs' appeal.

On April 3, 2023, Purple's founders filed a complaint against Purple LLC in the Delaware Court of Chancery. The complaint alleges that Purple LLC breached the limited liability company agreement of Purple LLC by failing to pay the full amount of tax distributions owed under the agreement. The plaintiffs seek damages of approximately $3.0 million in allegedly unpaid tax distributions as well as legal fees and expenses incurred in connection with the litigation. On June 13, 2023, Purple LLC filed an answer to the complaint denying the plaintiffs' allegations, setting forth its affirmative defenses, and requesting dismissal of all claims and entry of judgment in Purple LLC's favor. A trial date has been set for October 2026. The outcome of the litigation cannot be predicted at this stage in the proceedings. Purple LLC denies all allegations and intends to vigorously defend against these claims.

On April 16, 2024, Purple's founders, in their capacity as a former landlord of Purple LLC, brought a lawsuit against Purple LLC, as lessee, for amounts allegedly owed under a real estate lease which the parties terminated effective September 30, 2023. In the suit, the plaintiffs allege approximately $2.5 million in damages, based primarily on a dispute regarding whether Purple LLC left the premises in the condition required by the lease. The plaintiffs further claim approximately $0.8 million in holdover rent, as well as unspecified amounts in interest, late fees, liquidated damages, attorney fees and costs. Fact discovery is scheduled to conclude in 2026. The court has not yet set a date for trial. Purple LLC denies all allegations and intends to vigorously defend against these claims.

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements**

**(unaudited)**

On July 24, 2024, a former part-time employee filed a class action lawsuit against Purple LLC in California Superior Court in the County of Alameda alleging failure to pay all wages, failure to pay overtime pay rate, failure to provide all meal periods, and other employment-related causes of action. The suit seeks damages, interest, attorneys' fees, costs and other relief on behalf of all non-exempt California employees of Purple LLC during the applicable statutory periods. On September 30, 2024, the plaintiffs filed an amended complaint adding a claim for penalties under California's Private Attorneys General Act. Purple LLC and the plaintiffs mediated the claims on May 8, 2025, which resulted in the parties agreeing to a settlement. The settlement agreement has been signed by the parties and are currently waiting for the California Superior Court to approve the settlement.

On February 20, 2026, the U.S. Supreme Court issued a decision invalidating tariffs imposed under the International Emergency Economic Powers Act ("IEEPA"). The Company estimates that approximately $5.3 million of its previous tariff payments are subject to this ruling. On March 6, 2026, the Company filed a lawsuit in the U.S. Court of International Trade against the U.S. Customs and Border Protection ("CBP"), the CBP commissioner, and the United States of America seeking a full refund of all IEEPA tariffs that the Company has paid to the United States. The financial impact of these events is uncertain, as it is unclear to what extent duties will be refunded by CBP, what processes will govern such refunds, or if the Company can fully collect the related amounts claimed. No adjustments have been recorded in the accompanying unaudited condensed consolidated financial statements as the Company will apply the involuntary conversion model which results in recognition of recoveries when reimbursement is probable.

The Company is from time to time involved in various other claims, legal proceedings and complaints arising in the ordinary course of business. The Company does not believe that adverse decisions in any such pending or threatened proceedings, or any amount that the Company might be required to pay by reason thereof, would have a material adverse effect on the financial condition or future results of the Company.

**14. Related Party Transactions**

The Company has engaged in various transactions with entities or individuals which are considered related parties.

***Coliseum Capital Management, LLC***

Immediately following the Business Combination, Adam Gray was appointed to the Board. Mr. Gray is a manager of Coliseum Capital, LLC, which is the general partner of CCP and Coliseum Co-Invest Debt Fund, L.P. ("CDF"), and he is also a managing partner of Coliseum Capital Management, LLC ("CCM"), which is the investment manager of Blackwell and also manages investment funds and accounts. Mr. Gray has voting and dispositive control over securities held by CCP, CDF and Blackwell. In April 2023, Adam Gray was appointed Chairman of the Board of the Company as part of an agreement to resolve litigation that had been brought by Coliseum against the Company. Refer to Note 10— *Debt* for more information on the Related Party Loan and amendments*.*

 

**15. Stockholders' Equity**

***Class A Common Stock***

The Company has 210.0 million shares of Class A common stock authorized. Holders of the Company's Class A common stock are entitled to one vote for each share held on all matters to be voted on by the stockholders. Holders of Class A common stock and holders of Class B common stock voting together as a single class have the exclusive right to vote for the election of directors and on all other matters properly submitted to a vote of the stockholders. At March 31, 2026, 108.6 million shares of Class A common stock were outstanding.

***Class B Common Stock***

The Company has 90.0 million shares of Class B common stock authorized. Holders of the Company's Class B common stock will vote together as a single class with holders of the Company's Class A common stock on all matters properly submitted to a vote of the stockholders. Shares of Class B common stock may be issued only to InnoHold, their respective successors and assigns, as well as any permitted transferees of InnoHold. A holder may transfer their shares of Class B common stock to any transferee (other than the Company) only if such holder also simultaneously transfers an equal number of such holder's Class B Units to such transferee. The Class B common stock is not entitled to receive dividends, if declared by the Board, or to receive any portion of any such assets in respect of their shares upon liquidation, dissolution, distribution of assets or winding-up of the Company in excess of the par value of such stock. At March 31, 2026, 0.2 million shares of Class B common stock were outstanding.

***Preferred Stock***

The Company has 5.0 million shares of preferred stock authorized. The preferred stock may be issued from time to time in one or more series. The Board is expressly authorized to provide for the issuance of shares of the preferred stock in one or more series and to establish from time to time the number of shares to be included in each such series and to fix the voting rights, designations and other special rights or restrictions. At December 31, 2025, there were no shares of preferred stock outstanding. On June 27, 2024, 0.3 million shares of the Company's authorized shares of preferred stock were designated as Series C Junior Participating Preferred Stock, par value $0.0001 per share ("Series C Preferred Shares"). In conjunction with the termination of the NOL Rights Plan, the Company filed a Certificate of Elimination eliminating the Series C Junior Participating Preferred Stock, effective May 7, 2025. At March 31, 2026, there were no shares of preferred stock outstanding

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

***Warrants***

 ****

The Company issued warrants in connection with various financing transactions and agreements. The Company had the following warrants outstanding at March 31, 2026 and December 31, 2025 (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| 2024 Warrants | 20000 | 20000 |
| 2025 Warrants | 6230 | 6230 |
| 2025 Additional Warrants | 6557 | 6557 |
| SGI Warrants | 8000 | 8000 |
| &nbsp;&nbsp;&nbsp;Total Warrants | 40787 | 40787 |

---

The following table provides the exercise price and expiration date for each warrant tranche as of March 31, 2026:

---

| | | | |
|:---|:---|:---|:---|
|  | **Warrant Share Equivalent<br> (000's)** | **Exercise<br> Price<sup>(1)</sup>** | **Expiration Date** |
| 2024 Warrants | 20000 | $1.50 | January 23, 2034 |
| 2025 Warrants | 6230 | $1.50 | March 12, 2035 |
| 2025 Additional Warrants | 6557 | $1.50 | March 12, 2035 |
| SGI Warrants | 8000 | $1.50 | March 12, 2035 |

---

(1) Subject to adjustment.

While the Warrants are exercisable, the Company may call the Warrants for redemption in whole and not in part at any time at a price of $0.01 per share of Common Stock issuable upon exercise of the Warrants upon not less than 45 days' prior written notice of redemption to each holder. This redemption right is only available if the reported last sale price of the Common Stock equals or exceeds $24.00 per share on each of 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the holders. A holder of the Warrants will not have the right to exercise its Warrants, to the extent that after giving effect to such exercise, the holder (together with its affiliates) would beneficially own in excess of 49.9% of the shares of Common Stock outstanding immediately after giving effect to such exercise.

***Noncontrolling Interest***

Noncontrolling interest ("NCI") is the membership interest in Purple LLC held by holders other than the Company. At March 31, 2026 and December 31, 2025, the combined NCI percentage in Purple LLC was 0.15% and 0.15%, respectively. The Company has consolidated the financial position and results of operations of Purple LLC and reflected the proportionate interest held by all such Purple LLC Class B Unit holders as NCI.

**16. Income Taxes** 

The Company's sole material asset is Purple LLC, which is treated as a partnership for U.S. federal income tax purposes and for purposes of certain state and local income taxes. Purple LLC's net taxable income and any related tax credits are passed through to its members and are included in the members' tax returns, even though such net taxable income or tax credits may not have actually been distributed. While the Company consolidates Purple LLC for financial reporting purposes, the Company will be taxed on its share of earnings of Purple LLC not attributed to the noncontrolling interest holders, which will continue to bear their share of income tax on its allocable earnings of Purple LLC. The income tax burden on the earnings taxed to the noncontrolling interest holders is not reported by the Company in its consolidated financial statements under GAAP.

The Company reported de minimis income tax expense on a pretax loss of $30.5 million for the three months ended March 31, 2026 as compared to de minimis income tax expense on pretax loss of $19.1 million for the three months ended March 31, 2025. This resulted in an effective tax rate of (0.15%) for the three months ended March 31, 2026 as compared to (0.21%) for the three months ended March 31, 2025. The Company's effective tax rate for the three months ended March 31, 2026 differs from the statutory federal rate of 21% primarily due to the impact of the full valuation allowance recorded against the Company's deferred tax assets at March 31, 2026.

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

In connection with the Business Combination, the Company entered into a tax receivable agreement with InnoHold, which provides for the payment by the Company to InnoHold of 80% of the net cash savings, if any, in U.S. federal, state and local income tax that the Company actually realizes (or is deemed to realize in certain circumstances) in periods after the Closing as a result of (i) any tax basis increases in the assets of Purple LLC resulting from the distribution to InnoHold of the cash consideration, (ii) the tax basis increases in the assets of Purple LLC resulting from the redemption by Purple LLC or the exchange by the Company, as applicable, of Class B Paired Securities or cash, as applicable, and (iii) imputed interest deemed to be paid by the Company as a result of, and additional tax basis arising from, payments it makes under the agreement.

As noncontrolling interest holders exercise their right to exchange or cause Purple LLC to redeem all or a portion of their Class B Units, a tax receivable agreement liability may be recorded based on 80% of the estimated future cash tax savings that the Company may realize as a result of increases in the basis of the assets of Purple LLC attributed to the Company as a result of such exchange or redemption. The amount of the increase in asset basis, the related estimated cash tax savings and the attendant liability to be recorded will depend on the price of the Company's Class A common stock at the time of the relevant redemption or exchange.

The effects of uncertain tax positions are recognized in the consolidated financial statements if these positions meet a "more-likely-than-not" threshold. For those uncertain tax positions that are recognized in the consolidated financial statements, liabilities are established to reflect the portion of those positions it cannot conclude "more-likely-than-not" to be realized upon ultimate settlement. The Company's policy is to recognize interest and penalties related to unrecognized tax benefits on the income tax expense line in the accompanying consolidated statement of operations. Accrued interest and penalties would be included on the related tax liability line in the consolidated balance sheet. As of March 31, 2026, the Company had unrecognized tax benefits of $1.1 million.

**17. Net Loss Per Common Share**

Basic net income (loss) per common share is calculated by dividing net income (loss) attributable to common stockholders by the weighted average number of shares of Class A common stock outstanding during each period. Diluted net income (loss) per share reflects the weighted-average number of common shares outstanding during the period used in the basic net income (loss) computation plus the effect of common stock equivalents that are dilutive.

The following table sets forth the calculation of basic and diluted weighted average shares outstanding and net loss per share for the periods presented (in thousands, except per share amounts):

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br> March 31,** | **Three Months Ended<br> March 31,** |
|  | **2026** | **2025** |
| Numerator: |  |  |
| Net loss attributable to Purple Innovation, Inc. – basic | $(30541) | $(19137) |
| Less – net loss attributed to noncontrolling interest |  |  |
| Net loss attributable to Purple Innovation, Inc. – diluted | $(30541) | $(19137) |
| Denominator: |  |  |
| Weighted average shares—basic | 108386 | 107596 |
| Add – dilutive effect of Class B shares |  |  |
| Weighted average shares—diluted | 108386 | 107596 |
| Net loss per common share: |  |  |
| Basic | $(0.28) | $(0.18) |
| Diluted | $(0.28) | $(0.18) |

---

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

The Company excludes from the diluted net loss per common share computation potentially dilutive securities related to warrants, equity awards and convertible shares of Class B common stock when their exercise or performance vesting price is greater than the average market price of the Company's common stock or they are otherwise anti-dilutive. Potentially dilutive securities that have been excluded from the calculation of diluted net loss per common share are as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br> March 31,** | **Three Months Ended<br> March 31,** |
|  | **2026** | **2025** |
| Warrants | 40787 | 26230 |
| Restricted stock units | 1506 | 3397 |
| Stock Options | 500 | 529 |
| Class B Shares | 163 | 165 |

---

**18. Equity Compensation Plans**

***2017 Equity Incentive Plan***

The Purple Innovation, Inc. 2017 Equity Incentive Plan (the "2017 Plan") provides for grants of stock options, stock appreciation rights, restricted stock units and other stock-based awards. Directors, officers and other employees, as well as others performing consulting or advisory services for the Company and its subsidiaries, are eligible for grants under the 2017 Plan. As of March 31, 2026, an aggregate of 2.7 million shares remain available for issuance or use under the 2017 Plan.

***Employee Stock Options***

The following table summarizes the Company's total stock option activity for the three months ended March 31, 2026:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Options<br> (in thousands)** | **Weighted <br> Average <br> Exercise <br> Price** | **Weighted <br> Average <br> Remaining <br> Contractual <br> Term in <br> Years** | **Intrinsic <br> Value<br> (in thousands)** |
| Options outstanding as of January 1, 2025 | 500 | $6.82 | 1.3 | $— |
| Granted |  |  |  |  |
| Exercised |  |  |  |  |
| Forfeited |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Options outstanding as of March 31, 2026 | 500 | $6.82 | 1 | $— |

---

Outstanding and exercisable stock options as of March 31, 2026 are as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Options Outstanding** | **Options Outstanding** | **Options Exercisable** | **Options Exercisable** | **Options Exercisable** |
|<br>**Exercise Prices** | **Number of<br> Options<br> Outstanding<br> (in thousands)** | **Weighted<br> Average<br> Remaining Life<br> (Years)** | **Number of<br> Options<br> Exercisable<br> (in thousands)** | **Weighted<br> Average<br> Remaining Life <br> (Years)** | **Intrinsic<br> Value <br> (in thousands)** |
| $6.82 | 500 | 1 | 500 | 1 | $— |

---

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

The estimated fair value of Company stock options is amortized over the options vesting period on a straight-line basis. All outstanding stock options were vested as of January 1, 2026 and there was no remaining unrecognized stock compensation cost. There was no stock option expense for the three months ended March 31, 2026 and was de minimis for the three months ended March 31, 2025.

***Employee Restricted Stock Units***

The following table summarizes the Company's restricted stock unit activity for the three months ended March 31, 2026:

---

| | | |
|:---|:---|:---|
|  | **Number<br> Outstanding<br> (in thousands)** | **Weighted<br> Average<br> Grant Date<br> Fair Value** |
| Nonvested restricted stock units as of January 1, 2026 | 3141 | $1.25 |
| Granted |  |  |
| Vested | (707) | 1.39 |
| Forfeited | (928) | 1.87 |
| Nonvested restricted stock units as of March 31, 2026 | 1506 | $0.80 |

---

The Company recorded restricted stock unit expense of $0.2 million and $0.4 million during the three months ended March 31, 2026 and 2025, respectively.

For restricted stock units outstanding as of March 31, 2026, there were $0.8 million of total unrecognized stock compensation costs with a remaining recognition period of 1.5 years.

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

***Aggregate Non-Cash Stock-Based Compensation***

The Company has accounted for all stock-based compensation under the provisions of ASC 718 *Compensation—Stock Compensation*. This standard requires the Company to record a non-cash expense associated with the fair value of stock-based compensation over the requisite service period.

The following table summarizes the aggregate non-cash stock-based compensation recognized in the statement of operations for stock awards, employee stock options and employee restricted stock units (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br> March 31,** | **Three Months Ended<br> March 31,** |
|  | **2026** | **2025** |
| &nbsp;&nbsp;&nbsp;Cost of revenues | $(16) | $103 |
| &nbsp;&nbsp;&nbsp;Marketing and sales | 8 | (176) |
| &nbsp;&nbsp;&nbsp;General and administrative | 162 | 363 |
| &nbsp;&nbsp;&nbsp;Research and development | 2 | 78 |
| Total non-cash stock-based compensation | $156 | $368 |

---

**19. Employee Retirement Plan**

In July 2018, the Company established a 401(k) plan that qualifies as a deferred compensation arrangement under Section 401 of the IRS Code. All eligible employees over the age of 18 and with 4 months' service are eligible to participate in the plan. The plan provides for the Company to match employee contributions up to 5% of eligible earnings. Company contributions immediately vest. The Company's matching contribution expense was $0.8 million and $1.1 million for the three months ended March 31, 2026 and 2025, respectively.

**20. Segment Information and Concentrations**

The Company designs and manufactures a variety of innovative, branded and premium comfort products, including mattresses, pillows, cushions, bases, sheets, and other products. The Company has one reportable segment that operates an omni-channel distribution strategy which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. The Company's one segment markets and sells products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

The accounting policies for the Company's one segment are the same as those described in Note 2 – *Summary of Significant Accounting Policies*. The CODM assesses performance for the segment and decides how to allocate resources based on consolidated net income or loss as reported in the consolidated statement of operations. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets. The Company does not have intra-entity sales or transfers.

The CODM uses consolidated net loss to evaluate earnings generated from segment assets (return on assets) in deciding whether to reinvest profits into its single reportable segment or into other parts of the entity, such as for acquisitions. Consolidated net loss is also used to monitor budget versus actual results. The monitoring of budgeted versus actual results are used in assessing the segment's performance and in establishing management's compensation.

**PURPLE INNOVATION, INC. Notes to Condensed Consolidated Financial Statements (unaudited)**

The following table summarizes segment revenue, significant segment expenses, other segment items and segment profit or loss (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br> March 31,** | **Three Months Ended<br> March 31,** |
|  | **2026** | **2025** |
| Revenues, net | $95730 | $104171 |
| &nbsp;&nbsp;&nbsp;Reductions (additions): |  |  |
| &nbsp;&nbsp;&nbsp;Cost of revenues | 60535 | 62207 |
| &nbsp;&nbsp;&nbsp;Cost of revenues – restructuring related charges |  | 918 |
| &nbsp;&nbsp;&nbsp;Advertising expense | 11342 | 14602 |
| &nbsp;&nbsp;&nbsp;Marketing sales expense | 5132 | 7187 |
| &nbsp;&nbsp;&nbsp;Wholesale marketing and sales expense | 4932 | 4323 |
| &nbsp;&nbsp;&nbsp;Showrooms marketing and sales expense | 10151 | 10514 |
| &nbsp;&nbsp;&nbsp;General and administrative expense | 18033 | 14487 |
| &nbsp;&nbsp;&nbsp;Research and development expense | 2448 | 2452 |
| &nbsp;&nbsp;&nbsp;Restructuring, impairment and other related charges |  | 1960 |
| &nbsp;&nbsp;&nbsp;Other segment items, net <sup>(1)</sup> | 13686 | 4646 |
| &nbsp;&nbsp;&nbsp;Income tax expense | 47 | 41 |
| &nbsp;&nbsp;&nbsp;Net loss attributable to noncontrolling interest | (35) | (29) |
| Net reductions | 126271 | 123308 |
| Segment net loss | $(30541) | $(19137) |

---

(1) Other segment items, net include interest expense, other (income) expense, net, loss on extinguishment of debt, and change in fair value of warrant liabilities.

The Company classifies products into two major categories: sleep products and other. Sleep products include mattresses, platforms, adjustable bases, mattress protectors, pillows and sheets. Other products include cushions and various other products. In the three months ended March 31, 2026 and 2025 sales of other products accounted for less than 3.0% of net revenues.

The Company defines international revenues as sales to customers located outside of the United States. In the three months ended March 31, 2026 and 2025 international customers accounted for less than 1.0% of net revenues.

The Company had one individual customer that accounted for approximately 40.8% and 36.0% of accounts receivable at March 31, 2026 and 2025, respectively, and approximately 8.3% and 11.9% of net revenue during the three months ended March 31, 2026 and 2025, respectively.

The Company currently obtains materials and components used in production from outside sources. As a result, the Company is dependent upon suppliers that in some instances, are the sole source of supply. The Company is continuing efforts to dual-source key components. The failure of one or more of the Company's suppliers to provide materials or components on a timely basis could significantly impact the results of operations. The Company believes that it can obtain these raw materials and components from other sources of supply in the ordinary course of business, although an unexpected loss of supply over a short period of time may not allow for the replacement of these sources in the ordinary course of business.

The Company maintains its cash balances in financial institutions based in the United States that are insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000 for each financial institution per entity. At times, the Company's cash balance deposited at financial institutions exceed the federally insured deposit limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk related to these deposits.

**ITEM 2. <u>MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</u>**

The following discussion is intended to provide a review of the operating results and financial condition of Purple Innovation, Inc. The discussion should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in "Part I. Item 1. Financial Statements." Capitalized terms used in this "Part I. Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations and not otherwise defined shall have the meanings set forth in "Part I. Item. 1 Financial Statements."

**FORWARD-LOOKING STATEMENTS**

This quarterly report on Form 10-Q (this "Quarterly Report") contains forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended ("the "Exchange Act"), that represent our current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.

All forward-looking statements included in this Quarterly Report are made only as of the date hereof. It is routine for our internal projections and expectations to change throughout the year, and any forward-looking statements based upon these projections or expectations may change prior to the end of the next quarter or year. In addition, any statements that refer to projections of our future financial performance, our anticipated growth and trends in our businesses (including the discussion under the heading "Outlook for Growth"), and other characterizations of future events or circumstances are forward-looking statements.

We caution and advise readers that these statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict, including those included in the "Risk Factors" section of this Quarterly Report and in our Annual Report on Form 10-K filed with the SEC on March 31, 2026. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements and investors are cautioned not to place undue reliance on any such statements. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

**Overview of Our Business**

Our mission is to deliver the greatest sleep ever invented.

We began as a digitally-native vertical brand founded on comfort product innovation with premium offerings, and have since expanded into brick & mortar stores as a true omni-channel brand. We offer a variety of innovative, branded and premium comfort products, including mattresses, pillows, cushions, bases, sheets and more. Our products are the result of decades of innovation and investment in proprietary and patented comfort technologies and the development of our own manufacturing processes. Our proprietary Hyper-Elastic Polymer gel technology underpins many of our comfort products and provides a range of benefits that differentiate our products from our competitors. Specially engineered to relieve pressure, maintain an ideal body temperature, and provide instantly adaptive support, Purple's patented technology has been tested rigorously within medical and consumer applications for over 30 years. Originally designed for use in hospital beds and wheelchairs, we adapted this unique pressure-relieving material for our mattresses, pillows and other cushion products.

We market and sell our products via our direct-to-consumer channel, which includes Purple.com (our direct-to-consumer e-commerce), Purple showrooms, our customer contact center and online marketplaces (collectively "DTC"), and our wholesale channel through retail brick-and-mortar and online wholesale partners.

**Organization**

Our business consists of Purple Inc. and its consolidated subsidiary, Purple LLC. As the sole managing member of Purple LLC, Purple Inc., through its officers and directors, is responsible for all operational and administrative decision making and control of the day-to-day business affairs of Purple LLC without the approval of any other member. At March 31, 2026, Purple Inc. had a 99.85% economic ownership interest in Purple LLC while Class B unit holders had the remaining 0.15%.

**Recent Developments in Our Business**

*Operational Developments* 

We entered 2026 building on the progress we made in the fourth quarter, and our first quarter reflects continued progress and greater consistency across our channels. Trends were solid during the quarter, with growth in our showroom and wholesale channels. The E-commerce channel also improved sequentially declining 10% in the first quarter year over year compared to down 15% in the prior period year over year, reflecting more disciplined marketing execution and early signs of improved conversion. Importantly, we continue to see the benefits of actions taken last year reflected in our operating expense performance. This progress is a direct result of the changes we've made to the business, not a recovery of the broader market, reinforcing the durability of the model we've been building.

*Impact of Revenue Presentation for Certain Product Arrangements*

Revenue for certain product arrangements is presented differently depending on the nature of the underlying manufacturing relationships and the application of ASC 606—*Revenue from Contracts with Customers*. Under the guidance, payments to third-party manufacturers, including manufacturers under common control with certain customers, are evaluated to determine whether they are economically linked to an underlying customer arrangement. For certain customer-specific or exclusive product programs where the manufacturer is under common control with the customer, the Company has concluded that payments to the manufacturer are economically linked to the customer relationship and therefore represent consideration payable to a customer. As a result, these payments are recorded as a reduction of revenue, and revenue is presented on a net basis. The Company recorded $4.9 million in consideration paid as a reduction of revenue in the unaudited condensed consolidated statement of operations for the three months ended March 31, 2026. This presentation results in reported revenue being lower than the gross amount billed to the customer. While the net presentation affects reported revenue, it does not impact gross profit dollars for these arrangements. The distinction reflects the application of GAAP to different fact patterns rather than a difference in the underlying economics of the transactions.

*Debt Financings*

On March 24, 2026, the Loan Parties entered into the Third Amendment with the Lenders, which revised the maturity date under the Amended A&R Credit Agreement from December 31, 2026, to April 30, 2027 and waived certain requirements and events of default relating to the going concern qualification in our December 31, 2025 financial statements. In connection with the Third Amendment, the Loan Parties agreed to pay to the Lenders an amendment fee in the aggregate amount of $1.6 million, equal to 1.25% pro rata based on each Lender's outstanding principal amount (the "Amendment Fee"). Of the Amendment Fee, approximately $1.3 million is payable-in-kind by adding such amount to the 2025 Lenders' outstanding principal amount. The remaining $0.3 million of the Amendment Fee was paid in cash to the other lenders. In connection with the Third Amendment, the Loan Parties also agreed to reimburse the 2025 Lenders for certain expenses in the amount of $0.3 million.

*Review of Strategic Alternatives* 

We have engaged with multiple parties about a broad range of opportunities to maximize shareholder value, including, but not limited to, a merger, sale or other strategic or financial transaction. The Board has formed a special committee of independent directors and we have engaged a financial advisor to support them in evaluating a range of options and exploring other potential strategic alternatives. If we are unsuccessful in engaging in a favorable strategic alternative, then our ability to grow our business and compete with larger, including combined, competitors may be adversely affected.

 

*Impact of United States Tariff Policy*

We continue to actively manage the impact of recent United States tariff policies. Importantly, all of our mattresses are manufactured in the United States, and about 15% of our cost of goods is tied to products sourced from overseas. This limited exposure is primarily concentrated in the textile side of the business, which includes sheets and mattress covers, but also includes the import of bases and foundations. Tariffs impacted us by approximately $1.0 million during the three months ended March 31, 2026 due to our mitigation efforts which have reduced the overall impact to our initial expectations. The tariff landscape remains fluid, and we are actively evaluating sourcing alternatives and pricing strategies on a case-by-case basis. We believe that our vertically integrated model and strong vendor relationships give us the flexibility to remain agile and responsive to changes in tariff policies, and we believe that we will be able to partially mitigate these impacts through a combination of supply chain repositioning, vendor collaborations, and selective pricing actions. On March 6, 2026, we filed a lawsuit in the U.S. Court of International Trade against the U.S. Customs and Border Protection ("CBP"), the CBP commissioner, and the United States of America seeking a full refund of the $5.3 million in tariffs imposed under the International Emergency Economic Powers Act that the Company has paid to the United States (See Note 13 – *Commitments and Contingencies, Legal Proceedings).*

 

**Executive Summary – Results of Operations**

Net revenues decreased $8.4 million, or 8.1%, to $95.7 million for the three months ended March 31, 2026 compared to $104.2 million for the three months ended March 31, 2025. The drop in revenue was primarily due to a decrease in e-commerce sales and recognized wholesale revenue. From a sales channel perspective, e-commerce net revenues decreased $4.8 million, or 10.6%, wholesale net revenues decreased $4.5 million or 11.0% and showroom net revenues increased $0.9 million, or 4.8%. The decrease in wholesale revenue was due mainly to $4.9 million in payments to a manufacturer that is under common control with a customer and represents consideration paid to a customer. Accordingly, these payments are recorded as a reduction in revenue. The decreases were partially offset by our showroom net revenue increase of $0.9 million or 4.8%. The increase in our showrooms channel represents a 7.0% year-over-year increase for all stores that have been open for 13 or more months. This is the third consecutive quarter of year-over-year growth in the showrooms channel, driven by increased order values through effective upselling and product bundling.

Gross profit decreased $5.9 million, or 14.3%, to $35.2 million for the three months ended March 31, 2026 compared to $41.0 million for the three months ended March 31, 2025. Our gross profit percentage decreased to 36.8% of net revenues in the first quarter of 2026 from 39.4% in the first quarter of 2025 due to our strategic investment in Purple Royale floor models to support the Mattress Firm rollout, as well as modest manufacturing overhead deleverage driven by lower production volumes and less favorable absorption of fixed costs.

Operating expenses decreased $3.5 million, or 6.3% to $52.0 million for the three months ended March 31, 2026 compared to $55.5 million for the three months ended March 31, 2025. This decrease was driven by a $3.3 million decrease in advertising spending, a $2.8 million decrease in employee related expenses and $2.0 million decrease in restructuring related costs from last year, partially offset by $4.6 million in strategic alternative and other costs.

Total other expense, net increased $9.0 million, or 194.6% to $13.7 million for the three months ended March 31, 2026 compared to $4.6 million for the three months ended March 31, 2025. The other expense, net in the first quarter of 2026 consists of interest expense of $8.2 million and a $7.0 million loss on change in fair value of warrants, partially offset by $1.5 million in other income. The other expense, net in the first quarter of 2025 consists of interest expense of $4.8 million, partially offset by $0.2 million in other income and gain on change in fair value of warrants.

Net loss attributable to Purple Inc. was $30.5 million for the three months ended March 31, 2026 compared to a net loss of $19.1 million for the three months ended March 31, 2025. The $11.4 million increase in net loss was primarily due to lower gross margins and the increase in loss from change in fair value of the warrants, partially offset by reduced operating expenses.

**Outlook for Growth** 

The way we think about the business today is fundamentally different than a year ago. Last year was about reshaping the business for a tougher market – right sizing our cost structure, strengthening the foundation and restoring profitability. Now, we are focused on growth with our strategic focus areas that build on what is already working and how we are running our business. We believe we are well positioned to grow our business given our new grid innovation, evolved messaging strategy, our new cost structure and other cost saving initiatives. Our Path to Premium Sleep strategy remains focused on the following three priorities to drive growth:

●  ***Knowing Our Consumer.*** Knowing our consumer continues to shape how we show up across all channels. We have shifted away from promotion-led messaging toward clearer, benefit driven marketing focused on our differentiated technology and how we deliver better sleep. Our *Less Pain, Better Sleep* positioning continues to resonate, providing a consistent, consumer-led message that translates across e-commerce, retail, and wholesale channels. We are making our differentiation clearer, our content more educational and our local marketing more effective at converting awareness into foot traffic. We continue to make changes to our creative approach and how we guide consumers through the online purchase journey with a more focused and tactical path to identifying the right mattress.

●  ***Delivering Better Sleep.*** Our innovation continues to resonate with consumers, with our premium products maintaining strong interest in both wholesale and showroom channels. We saw a strong initial response to the launch of Purple Royale, our new premium offering developed in partnership with Mattress Firm. Additionally, Rejuvenate 2.0 continues to outperform our expectations with strong demand. This performance reinforces the strength of our premium positioning and the resonance of our innovation with consumers. We are also seeing a positive halo effect across the portfolio, supporting performance in adjacent categories. We are focused on elevating the full consumer journey across both owned and partner channels. This includes improving how we present and explain our technology in-store, with greater emphasis on pain relief and more effective use of demonstrations and digital support. This is resulting in improved engagement from retail sales associates, particularly within our wholesale channel, as our product storytelling continues to resonate. We have also made changes to our online sales approach, enhancing live customer care and follow-up to better replicate the in-store experience in a digital environment, which is helping improve engagement and close rates. At the same time, we're enhancing our delivery experience to ensure a more consistent and credible brand experience from purchase through fulfillment. These improvements are helping reinforce our value proposition and support stronger conversion.

●  ***Executing with Financial Discipline.*** We have taken meaningful steps to resize and simplify the business, and we are seeing those benefits reflected in our operating efficiency and cost structure. These actions have created a more stable foundation as we shift toward growth. In the first quarter, gross margin came in below our normal 40% baseline, primarily driven by higher levels of floor model discounts associated with the Purple Royale rollout at Mattress Firm. We view this as temporary, and as the floor model transition normalizes, we expect improved contribution from Purple Royale. We've seen similar dynamics during prior transitions and would expect a comparable normalization as floor model activity moderates. At the same time, we are making continued progress in our underlying cost structure, particularly across sourcing, operations, and fulfillment, supported by ongoing productivity initiatives and supply chain optimization efforts. We are also actively managing a more dynamic cost environment, including tariff dynamics and rising input costs. Our mitigation efforts are well underway, including diversifying our supplier base, expanding multi-sourcing, and selectively in-sourcing key components, such as pillows, where we see both cost and quality benefits.

There is no guarantee that we will be able to effectively execute on these initiatives, which are subject to risks, uncertainties, and assumptions that are difficult to predict, including the risks described in the "Risk Factors" section of this Quarterly Report and in our Annual Report on Form 10-K filed with the SEC on March 31, 2026 and elsewhere herein. Therefore, actual results may differ materially and adversely from those described above. In addition, we may, in the future, adapt these focuses in response to changes in the market or our business.

**Operating Results for the Three Months Ended March 31, 2026 and 2025**

The following table sets forth for the periods indicated, our results of operations and the percentage of total revenue represented in our unaudited condensed consolidated statements of operations (dollars in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
|  | **2026** | **% of<br> Net Revenues** | **2025** | **% of<br> Net Revenues** |
| Revenues, net | $95730 | 100.00% | $104171 | 100.0% |
| Cost of revenues: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cost of revenues | 60535 | 63.2 | 62207 | 59.7 |
| &nbsp;&nbsp;&nbsp;Cost of revenues - restructuring related charges |  |  | 918 | 0.9 |
| Total cost of revenues | 60535 | 63.2 | 63125 | 60.6 |
| Gross profit | 35195 | 36.8 | 41046 | 39.4 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Marketing and sales | 31557 | 33.0 | 36626 | 35.2 |
| &nbsp;&nbsp;&nbsp;General and administrative | 18033 | 18.8 | 14487 | 13.9 |
| &nbsp;&nbsp;&nbsp;Research and development | 2448 | 2.6 | 2452 | 2.4 |
| &nbsp;&nbsp;&nbsp;Restructuring, impairment and other related charges |  |  | 1960 | 1.9 |
| Total operating expenses | 52038 | 54.4 | 55525 | 53.3 |
| Operating loss | (16843) | (17.6) | (14479) | (13.9) |
| Other income (expense): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense | (8219) | (8.6) | (4764) | (4.6) |
| &nbsp;&nbsp;&nbsp;Other income, net | 1491 | 1.6 | 69 | 0.1 |
| &nbsp;&nbsp;&nbsp;Change in fair value – warrant liabilities | (6958) | (7.3) | 49 |  |
| Total other expense, net | (13686) | (14.3) | (4646) | (4.5) |
| Net loss before income taxes | (30529) | (31.9) | (19125) | (18.4) |
| &nbsp;&nbsp;&nbsp;Income tax expense | (47) |  | (41) |  |
| Net loss | (30576) | (31.9) | (19166) | (18.4) |
| &nbsp;&nbsp;&nbsp;Net loss attributable to noncontrolling interest | (35) |  | (29) |  |
| Net loss attributable to Purple Innovation, Inc. | $(30541) | (31.9) | $(19137) | (18.4) |

---

*Revenues, Net*

Net revenues decreased $8.4 million, or 8.1%, to $95.7 million for the three months ended March 31, 2026 compared to $104.2 million for the three months ended March 31, 2025. This decrease was primarily driven by our e-commerce and wholesale recognized revenue. From a sales channel perspective, e-commerce net revenues decreased $4.8 million, or 10.6%, wholesale net revenue decreased $4.5 million or 11.0% and showroom net revenues increased $0.9 million, or 4.8%. The decrease in wholesale revenue was due mainly to $4.9 million in payments to a manufacturer that is under common control with a customer and represents consideration paid to a customer. Accordingly, these payments are recorded as a reduction in revenue.

 

*Total Cost of Revenues*

Total cost of revenues decreased $2.6 million, or 4.1%, to $60.5 million for the three months ended March 31, 2026, compared to $63.1 million for the three months ended March 31, 2025. This decrease was due primarily to $4.9 million in costs associated with a manufacturer that is affiliated with a customer recorded as reduction of revenue. This decrease was partially offset by less favorable absorption of fixed costs from lower production volumes. Our gross profit percentage decreased to 36.8% of net revenues in the first quarter of 2026 from 39.4% in the first quarter of 2025, due to our strategic investment in Purple Royale floor models to support the Mattress Firm rollout, as well as modest manufacturing overhead deleverage driven by lower production volumes and less favorable absorption of fixed costs.

 

*Marketing and Sales*

Marketing and sales expense decreased $5.1 million, or 13.8%, to $31.6 million for the three months ended March 31, 2026 compared to $36.6 million for the three months ended March 31, 2025. This decrease primarily consisted of a $3.3 million decrease in advertising spend, a $1.3 million decrease in employee related expenses due to head count reductions and $0.2 million decrease in all other marketing and sales expenses.

*General and Administrative*

General and administrative expense increased $3.5 million, or 24.5%, to $18.0 million for the three months ended March 31, 2026 compared to $14.5 million for the three months ended March 31, 2025. This increase was due to a $4.3 million increase in strategic alternative costs and an increase of $0.7 million in all other general and administrative costs, partially offset by a $1.4 million decrease in employee related costs due to headcount reductions.

 

*Research and Development*

Research and development expense was flat to prior year at $2.4 million for the three months ended March 31, 2026 compared to the three months ended March 31, 2025.

*Restructuring, Impairment and Other Related Charges*

 

There were no restructuring, impairment and other related charges for the three months ended March 31, 2026 as all restructuring activities were completed in 2025. We incurred $2.0 million of restructuring, impairment and other related charges during the three months ended March 31, 2025.

*Operating Loss*

Operating loss increased $2.4 million, or 16.3%, to $16.8 million, for the three months ended March 31, 2026 compared to $14.5 million for the three months ended March 31, 2025. This increase in our operating loss is the result of a lower gross profit percent and increases in strategic alternative costs, partially offset by reduced advertising spend and lower headcount costs.

*Interest Expense*

Interest expense totaled $8.2 million for the three months ended March 31, 2026 compared to $4.8 million for the three months ended March 31, 2025. This increase was primarily due to additional interest incurred on a higher principal balance on the Related Party Loan as the Company elected the paid-in-kind option on monthly interest over the past 12 months.

*Other Income, Net*

 

Other income increased to $1.5 million for the three months ended March 31, 2026 compared to $0.1 million for the three months ended March 31, 2025. This increase was mainly due to $1.3 million received for sublease rent payments on facilities we are no longer using and have subleased to other parties. 

 

*Change in Fair Value – Warrant Liabilities*

 

Our Warrants contain certain provisions that did not meet the criteria for equity classification and therefore are recorded as liabilities with a re-measurement of fair value at each reporting date. We incurred a $7.0 million loss on the change in fair value of our warrant liabilities for the three months ended March 31, 2026 related to the increase in fair value from the previous reporting date. For the three months ended March 31, 2025, we recognized a negligible gain related to the net decrease in fair value of the warrant liability.

*Income Tax (Expense) Benefit* 

We had a de minimis income tax expense for the three months ended March 31, 2026 and 2025. The income tax expense amounts in both the first quarter of 2026 and 2025 were related to various state taxes.

 

*Noncontrolling Interest*

We calculate net loss attributable to noncontrolling interests on a quarterly basis using their weighted average ownership percentage. Net loss attributed to noncontrolling interests was negligible for the three months ended March 31, 2026 and 2025.

**Liquidity and Capital Resources**

Our principal sources of funds are cash flows from operations and cash and cash equivalents on hand, supplemented with borrowings made pursuant to various loan agreements. Principal uses of funds consist of capital expenditures, working capital needs, operating lease payment obligations and investing in innovation. In accordance with the terms of our various loan agreements, we have elected to pay interest in kind on our loans to reduce cash obligations. Our working capital needs depend largely upon the timing of cash receipts from product sales, payments to vendors and others, changes in inventories, and operating lease payment obligations. Our cash and cash equivalents and working capital positions were $25.0 million and $22.4 million, respectively, as of March 31, 2026 compared to $24.3 million and $35.2 million, respectively, as of December 31, 2025. Cash used for capital expenditures was $2.0 million and $2.1 million for the three months ended March 31, 2026 and 2025. Our capital expenditures in 2026 have primarily consisted of additional investments made in our manufacturing operations and showroom facilities. Additional details regarding our current debt are described above in Note 10 - *Debt*.

Our financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. In connection with the preparation of the consolidated financial statements for the year ended December 31, 2025, we conducted an evaluation as to whether there were conditions and events, considered in the aggregate, which raised substantial doubt as to our ability to continue as a going concern within one year after the date of the issuance of such financial statements.

We had cash and cash equivalents of approximately $25.0 million and an accumulated deficit of $655.8 million at March 31, 2026. We incurred a net loss of $30.5 million and net cash provided by operating activities and net cash used in investing activities was $3.0 million and $2.0 million, respectively, for the three months ended March 31, 2026. We have a history of recurring net losses and cash used in operations, an accumulated deficit, and requiring additional capital to fund our operations.

The funds we have on hand and any follow-on capital, if needed, will be used to fund our operations and invest in the business to expand sales and marketing efforts, as well as to invest in innovation. As described below, we have implemented plans that we believe will both increase our revenues from the sales of our products and achieve cost savings within the next year, sufficient to generate positive operating cash flow levels. However, we may be adversely impacted by uncertain market conditions and there can be no assurance that we will be successful in this regard. If such plans are not successful, we may need to raise additional capital in order to support operations and business initiatives. Access to additional capital is uncertain and not within our control. Accordingly, there is substantial doubt about our ability to continue as a going concern.

We have taken a number of actions to increase cash flow and support our operations and strategies. In August 2024, we implemented the Restructuring Plan (as defined below) to consolidate manufacturing operations resulting in cost savings. We have realized and plan to continue to realize direct material cost savings by concentrating efforts on driving gross margin improvement through various methods such as selective pricing actions, continued mix shift towards the Restore and Rejuvenate collections, and by driving cost savings through supply chain initiatives and manufacturing efficiency. We have delivered direct material cost savings from our supplier diversification efforts, improved scrap and yield results from continuous improvements, and outbound freight costs reflect cost improvements along with improved delivery reliability. We have been successful in subleasing the two manufacturing facilities that were vacated as part of the Restructuring Plan. We have also taken additional cost-saving initiatives in 2025 and the beginning of 2026 to reduce headcount and streamline responsibilities and reporting structure. Further, our plans include additional actions intended to improve liquidity and reduce costs, including planned optimization of advertising spend, limiting the number of new store openings, efforts to mitigate tariff impacts by managing the country of origin, and other cost-saving initiatives. We have elected to have interest paid-in-kind and added to the principal amount of the loans under the Amended and Restated Credit Agreement. On March 24, 2026, we executed the Third Amendment to the Amended and Restated Credit Agreement (the "Third Amendment") with the Lenders to extend the maturity date of the Amended and Restated Credit Agreement from December 31, 2026 to April 30, 2027. We are currently evaluating potential strategic alternatives and opportunities to achieve additional liquidity through one or more future debt refinancings.

Additionally, in May 2025, we entered into an agreement with Mattress Firm, Inc. ("Mattress Firm"), a business unit of Somnigroup International, Inc. ("SGI") to expand its inventory of the Company's products across SGI's national store network from approximately 5,000 mattress slots to a minimum of 12,000 mattress slots (see Note 13 — *Commitments and Contingencies, SGI Commercial Arrangements).* We are now represented in Mattress Firm's full store network and with the recent launch of Purple Royale, the exclusive Luxe product for Mattress Firm, we have expanded to all 12,000 committed slots. We have also expanded into more Costco clubs in the fourth quarter of 2025.

*Other Contractual Obligations*

 

Other material contractual obligations primarily include operating lease payment obligations. See Note 8 - *Leases* of the unaudited condensed consolidated financial statements for additional information on leases.

*Cash Flows for the Three Months Ended March 31, 2026 Compared to the Three Months Ended March 31, 2025*

The following summarizes our cash flows for the three months ended March 31, 2026 and 2025 as reported in our unaudited condensed consolidated statements of cash flows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br> March 31,** | **Three Months Ended<br> March 31,** |
|  | **2026** | **2025** |
| Net cash provided by (used in) operating activities | $2989 | $(23070) |
| Net cash used in investing activities | (2033) | (2144) |
| Net cash provided by (used in) financing activities | (346) | 17830 |
| Net increase (decrease) in cash | 610 | (7384) |
| Cash, beginning of the period | 24345 | 29011 |
| Cash, end of the period | $24955 | $21627 |

---

Cash provided by operating activities was $3.0 million for the three months ended March 31, 2026 compared to cash used in operating activities was $23.1 million for the three months ended March 31, 2025. The $26.1 million increase in year-over-year cash provided by operating activities included a $28.5 million increase in cash provided from the changes in operating assets and liabilities and an $8.8 million increase in non-cash cash adjustments, partially offset by a $11.4 million increase in net loss.

Cash used in investing activities reflected net capital expenditures of $2.0 million and $2.1 million for the three months ended March 31, 2026 and 2025, respectively. Capital expenditures in the first three months of 2026 primarily consisted of additional investments made in our manufacturing operations.

Cash used in investing activities was $0.3 million for the three months ended March 31, 2026 compared to cash provided in investing activities of $17.8 million during the three months ended March 31, 2025. Cash used in financing activities for 2026 consist of amendment fess paid in cash to certain lenders for the Third Amendment. Financing activities during the first three months of 2025 included $19.0 million of proceeds from the 2025 Amendment financing offset in part by $1.2 million in payments for debt issuance costs.

**Critical Accounting Estimates**

We discuss our critical accounting policies and estimates in *Management's Discussion and Analysis of Financial Condition and Results of Operations* in our 2025 Annual Report on Form 10-K filed with the SEC on March 31, 2026. There have been no significant changes in our critical accounting policies since the end of fiscal 2025.

**Available Information**

Our website address is www.purple.com. We make available free of charge on the Investor Relations portion of our website, investors.purple.com, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The inclusion of our website address in this report does not include or incorporate by reference into this report any information on our website.

We also use the Investor Relations portion of our website, investors.purple.com, as a channel of distribution of additional Company information that may be deemed material. Accordingly, investors should monitor this channel, in addition to following our press releases, SEC filings and public conference calls and webcasts. The contents of our website shall not be deemed to be incorporated herein by reference.

**ITEM 3. <u>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</u>**

**Interest Rate Risk**

Our operating results are subject to risk from interest rate fluctuations on the outstanding borrowings. Interest rate risk is highly sensitive due to many factors, including U.S. monetary and tax policies, U.S. and international economic factors and other factors beyond our control. The proceeds we received from the Related Party Loan entered into in January 2024 bears interest at a variable rate which exposes us to market risks relating to changes in interest rates. As of March 31, 2026, we had $132.5 million of variable rate debt associated with the Related Party Loan. Based on this debt level, an increase of 100 basis points in the effective interest rate on the outstanding debt amount would result in an increase in interest expense of approximately $1.3 million over the next 12 months.

We do not use derivative financial instruments for speculative or trading purposes, but this does not preclude our adoption of specific hedging strategies in the future.

**ITEM 4. <u>CONTROLS AND PROCEDURES</u>**

**(a) Evaluation of Disclosure Controls and Procedures**

Our management, with the participation of our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO" and together with the CEO, the "Certifying Officers"), evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Exchange Act). Our disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Certifying Officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Based upon this evaluation, and the above criteria, our Certifying Officers concluded that the Company's disclosure controls and procedures were effective as of March 31, 2026 at the reasonable assurance level.

**(b) Changes in Internal Controls Over Financial Reporting.**

There were no changes in our internal control over financial reporting during the quarter ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**PART II. OTHER INFORMATION**

**ITEM 1. <u>LEGAL PROCEEDINGS</u>**

The Company is from time to time involved in various claims, legal proceedings and complaints arising in the ordinary course of business. Please refer to Note 13 — *Commitments and Contingencies* to the unaudited condensed consolidated financial statements contained in this report for certain information regarding our legal proceedings.

**ITEM 1A. <u>RISK FACTORS</u>** 

The Company's business, reputation, results of operations, financial condition and stock price can be materially and adversely affected by a number of factors, whether currently known or unknown, including those described in Part I, Item 1A of the 2025 Annual Report on Form 10-K filed with the SEC on March 31, 2026 under the heading "Risk Factors." There have been no material changes from the risk factors previously disclosed in our 2025 Annual Report on Form 10-K filed with the SEC on March 31, 2026.

**ITEM 5. <u>OTHER INFORMATION</u>**

**<u>10b5-1 Trading Plans</u>**

During the first quarter of 2026, none of our directors or executive officers adopted or terminated any "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" as such terms are defined under Item 408 of Regulation S-K.

**ITEM 6. <u>EXHIBITS</u>**

---

| | |
|:---|:---|
| **Number** | **Description** |
| 10.1 | [Third Amendment to Amended and Restated Credit Agreement, dated as of March 24, 2026, by and among the Loan Parties and the Lenders (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on March 31, 2026).](http://www.sec.gov/Archives/edgar/data/1643953/000121390026036891/ea028245601ex10-1.htm) |
| 10.2\*+ | [Amendment to Amended and Restated Employment Agreement dated March 30, 2026, between Purple Innovation, Inc., and Robert DeMartini.](ea028623101ex10-2.htm) |
| 10.3\*+ | [Amendment to Performance Share Unit Agreement dated March 30, 2026, between Purple Innovation, Inc. and Todd E. Vogensen.](ea028623101ex10-3.htm) |
| 10.4\*+ | [Amendment to Restricted Share Unit Agreement dated March 30, 2026, between Purple Innovation, Inc. and Todd E. Vogensen.](ea028623101ex10-4.htm) |
| 31.1\* | [Certification by Robert T. DeMartini, Chief Executive Officer, pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ea028623101ex31-1.htm) |
| 31.2\* | [Certification by Todd E. Vogensen, Chief Financial Officer, pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ea028623101ex31-2.htm) |
| 32.1\*\* | [Certification by Robert T. DeMartini, Chief Executive Officer, pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ea028623101ex32-1.htm) |
| 32.2\*\* | [Certification by Todd E. Vogensen, Chief Financial Officer, pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ea028623101ex32-2.htm) |
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Link base Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |

---

\* Filed herewith. <br> \*\* Furnished herewith. <br> + Indicates management contract or compensatory plan.

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **PURPLE INNOVATION, INC.** | **PURPLE INNOVATION, INC.** |
| Date: April 28, 2026 | By: | /s/ Robert T. DeMartini |
|  |  | Robert T. DeMartini |
|  |  | Chief Executive Officer |
|  |  | (Principal Executive Officer) |
| Date: April 28, 2026 | By: | /s/ Todd E. Vogensen |
|  |  | Todd E. Vogensen |
|  |  | Chief Financial Officer |
|  |  | (Principal Financial Officer) |

---

---

| | | |
|:---|:---|:---|
| Date: April 28, 2026 | By: | /s/ George T. Ulrich |
|  |  | George T. Ulrich |
|  |  | VP Accounting and Financial Reporting |
|  |  | (Principal Accounting Officer) |

---

## Exhibit 10.2

**Exhibit 10.2**

March 30, 2026

Robert T. DeMartini

102 White Pine Canyon Road

Park City, UT 84060

---

| | |
|:---|:---|
| **Re:** | **<u>Amendment to Employment Agreement</u>** |

---

Dear Rob:

You and the Company agree that your Amended and Restated Employment Agreement by and between you and Purple Innovation, Inc. ("Company") dated March 19, 2022 (as amended by the amendments dated January 26, 2024, March 12, 2025, July 23, 2025, and August 7, 2025, your "<u>Employment Agreement</u>") is amended in the following respects:

&nbsp;&nbsp;&nbsp;&nbsp;1. The second sentence of Section 4(c) is revised in its entirety to read as follows:

In addition, subject to the release requirement described in the next sentence, and subject to Sections 26 and 27, Executive shall be entitled to (i) an amount equal to 1.5 times Executive's annual Base Salary, payable in substantially equal installments over eighteen (18) months in accordance with the Company's regular payroll practices ("Continued Salary Payments"), (ii) any earned but unpaid Annual Bonus for the year preceding the year of termination to be paid at same time earned annual bonuses are paid to other senior executives, (iii) the vesting of Executive's outstanding Company equity awards that vest based on continued service or employment shall fully accelerate so that such awards shall be become fully vested as of the Executive's date of termination, and (iv) subject to Executive's timely election of COBRA coverage, payment of the COBRA premiums for Executive and his eligible dependents for eighteen (18) months; however if such payments would violate applicable law (including, without limitation, Section 2716 of the Public Health Service Act) the Company may pay Executive the monthly cash value of the payments (items (i), (ii), (iii) and (iv) together, the "Change in Control Period Severance Benefits").

&nbsp;&nbsp;&nbsp;&nbsp;2. The introductory clause of Section 5 is revised in its entirety to read as follows:

During the period commencing on the Effective Date and ending twelve months following the termination of Executive's employment with the Company (and such twelve-month period is extended to an eighteen-month period if during a Change in Control Period Executive's employment is terminated without Cause by the Company or Executive resigns for Good Reason), Executive shall not directly or indirectly (whether for compensation or without compensation), as principal, agent, owner, partner, employee, consultant, shareholder, member, director, manager or officer, as the case may be, or otherwise howsoever (other than as the holder of an ownership interest of not more than 1% of the total outstanding stock of a publicly traded entity):

All other terms and conditions of your Employment Agreement remain in full force in effect.

Yours sincerely,

---

| | |
|:---|:---|
| <u>/s/ Adam Gray</u> |  |
| Adam Gray, | Date: March 30, 2026 |
| Chairman of the Board of Directors |  |
| Accepted and Agreed to by: |  |
| <u>/s/ Robert T. DeMartini</u> |  |
| Robert T. DeMartini | Date: March 30, 2026 |

---

## Exhibit 10.3

**Exhibit 10.3**

Amendment to

Performance Share Unit Agreement

This Amendment to Performance Share Unit Agreement (this "Amendment") is hereby entered into as of March 30, 2026 by and between Purple Innovation, Inc. (the "Company") and Todd Vogensen ("Participant"), and constitutes an amendment to Participant's Performance Share Unit Agreement with the Company dated March 14, 2024 (the "PSU Agreement"). Other than expressly herein set forth, the PSU Agreement remains in full force and effect without change.

WHEREAS, the PSU Agreement provides for an inducement grant under Nasdaq Listing Rule 5635(c)(4), and the Company intended for the PSU Agreement's performance period to end on the third anniversary of the participant's employment start date of October 16, 2023 rather than the third anniversary of the grant date of March 14, 2024, which was a drafting error;

WHEREAS, the Company and Participant wish to amend Section 4 of the PSU Agreement to change the last date of the Performance Period to October 16, 2026 to conform the PSU Agreement with the Company's intent.

NOW, THEREFORE, Section 4 of the PSU Agreement is hereby amended by replacing "March 14, 2027" with "October 16, 2026".

The parties hereto hereby agree to and adopt this Amendment which shall be and become effective as of the date hereinabove set forth.

---

| | | |
|:---|:---|:---|
| PURPLE INNOVATION, INC. | PURPLE INNOVATION, INC. |  |
| By: | /s/ Robert DeMartini | March 30, 2026 |
|  | Robert DeMartini, |  |
|  | Chief Executive Officer |  |
| <u>/s/ Todd Vogensen</u> | <u>/s/ Todd Vogensen</u> | March 30, 2026 |
| Todd Vogensen | Todd Vogensen |  |

---

## Exhibit 10.4

**Exhibit 10.4**

Amendment to

Restricted Share Unit Agreement

This Amendment to Restricted Share Unit Agreement (this "Amendment") is hereby entered into as of March 30, 2026 by and between Purple Innovation, Inc. (the "Company") and Todd Vogensen ("Participant"), and constitutes an amendment to Participant's Restricted Share Unit Agreement with the Company dated March 14, 2024 (the "RSU Agreement"). Other than expressly herein set forth, the RSU Agreement remains in full force and effect without change.

WHEREAS, the RSU Agreement provides for an inducement grant under Nasdaq Listing Rule 5635(c)(4), and the Company intended for the RSU Agreement to measure vesting on the first three anniversaries of the Participant's employment start date of October 16, 2023 rather than the grant date of March 14, 2024, which was a drafting error;

WHEREAS, the Company and Participant wish to amend Section 4 of the RSU Agreement to prospectively modify the vesting date of the third vesting installment to conform the RSU Agreement with the Company's intent.

NOW, THEREFORE, Section 4 of the RSU Agreement is hereby amended by replacing the vesting date of "March 14, 2027" with "October 16, 2026".

The parties hereto hereby agree to and adopt this Amendment which shall be and become effective as of the date hereinabove set forth.

---

| | | |
|:---|:---|:---|
| PURPLE INNOVATION, INC. | PURPLE INNOVATION, INC. |  |
| By: | /s/ Robert DeMartini | March 30, 2026 |
|  | Robert DeMartini, |  |
|  | Chief Executive Officer |  |
| /s/ Todd Vogensen | /s/ Todd Vogensen | March 30, 2026 |
| Todd Vogensen | Todd Vogensen |  |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATIONS** 

I, Robert T. DeMartini, certify that:

1. I
have reviewed this quarterly report on Form 10-Q of Purple Innovation, Inc.;

2. Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report;

3. Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The
registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in
Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;a) designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;b) designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;c) evaluated
the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and

&nbsp;&nbsp;&nbsp;&nbsp;d) disclosed
in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The
registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing
the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;a) all
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;b) any
fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal
control over financial reporting.

---

| | |
|:---|:---|
| Dated: April 28, 2026 | /s/ Robert T. DeMartini |
|  | Robert T. DeMartini, Chief Executive Officer |
|  | (Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATIONS** 

I, Todd E. Vogensen, certify that:

1. I
have reviewed this quarterly report on Form 10-Q of Purple Innovation, Inc.;

2. Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report;

3. Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The
registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in
Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;a) designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;b) designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;c) evaluated
the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and

&nbsp;&nbsp;&nbsp;&nbsp;d) disclosed
in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The
registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing
the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;a) all
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;b) any
fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal
control over financial reporting.

---

| | |
|:---|:---|
| Dated: April 28, 2026 | /s/ Todd E. Vogensen |
|  | Todd E. Vogensen, Chief Financial Officer<br> (Principal Financial Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION** 

In connection with the Quarterly Report on Form 10-Q of Purple Innovation, Inc. (the "Corporation") for the quarter ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Robert T. DeMartini, Chief Executive Officer of the Corporation, hereby certifies, pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended, and

&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Corporation.

---

| | |
|:---|:---|
| Dated: April 28, 2026 | /s/ Robert T. DeMartini |
|  | Robert T. DeMartini, Chief Executive Officer<br> (Principal Executive Officer) |

---

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION** 

In connection with the Quarterly Report on Form 10-Q of Purple Innovation, Inc. (the "Corporation") for the quarter ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Todd E. Vogensen, Chief Financial Officer of the Corporation, hereby certifies, pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended, and

&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Corporation.

---

| | |
|:---|:---|
| Dated: April 28, 2026 | /s/ Todd E. Vogensen |
|  | Todd E. Vogensen, Chief Financial Officer<br> (Principal Financial Officer) |

---